# Chapter 115: Stimulant Intoxication

# The Biological and Neurological Basis of Stimulant Intoxication

## Introduction

Stimulant intoxication is a transient, dose-dependent condition resulting from the administration of a psychoactive substance, leading to clinically significant disturbances in consciousness, cognition, perception, affect, or behavior (Sarkar et al., 2023; Daley & Douaihy, 2019). From a biological perspective, this state represents a profound and acute dysregulation of central nervous system (CNS) and autonomic nervous system (ANS) functioning, driven by a class of compounds known as sympathomimetics (Graddy & Rastegar, 2025; Graddy & Rastegar, 2020). This category includes well-established substances such as cocaine and amphetamines (including methamphetamine), as well as a growing number of new psychoactive substances (NPS), including synthetic cathinones like α-pyrrolidinopentiophenone (α-PVP or "flakka") (Graddy & Rastegar, 2025; Salani et al., 2018; Albishri et al., 2023).

The clinical presentation of acute stimulant intoxication is characterized by a spectrum of effects. At lower doses, users often seek the desired positive effects, which include heightened awareness, increased energy and alertness, euphoria, elevated mood, and decreased appetite and need for sleep (Graddy & Rastegar, 2025; Winger et al., 2004; Varı̀ et al., 2018). These effects are central to their recreational use and perceived utility as performance enhancers (Av, 1990; Outhoff, 2016). However, this state of heightened arousal is often accompanied by anxiety, restlessness, and irritability (Vilke & Ly, 2022; Meza-Ruiz & Zúñiga-Escobar, 2023).

As the dose increases or with high-potency formulations such as "crack" cocaine, the clinical picture can rapidly escalate into a medical and psychiatric emergency (Beebe & Walley, 1991; Vilke & Ly, 2022). The sympathomimetic surge manifests as tachycardia, severe hypertension, and hyperthermia (Graddy & Rastegar, 2025; Williams et al., 2000). Neurologically, high doses can precipitate seizures, movement disorders, and life-threatening cerebrovascular events, including ischemic and hemorrhagic strokes (Graddy & Rastegar, 2020; Meza-Ruiz & Zúñiga-Escobar, 2023; Lappin & Sara, 2019). Psychiatrically, the intoxication state can progress to severe agitation, paranoia, hallucinations, and a fully formed psychosis that can be clinically indistinguishable from primary psychotic disorders like schizophrenia (Vilke & Ly, 2022; Morton, 1999; Mauri, 2016; Dore & Sweeting, 2006). In its most extreme form, stimulant intoxication can manifest as excited delirium syndrome, a life-threatening condition characterized by extreme agitation, aggression, bizarre behavior, hyperthermia, and unexpected sudden death, often in the context of physical restraint (Shields et al., 2015; Ross & Hazlett, 2018; Maio & Maio, 2005).

Understanding the biological basis of stimulant intoxication is critical for both clinical management and public health. The diverse and often severe manifestations of this condition are not random but are the direct consequence of the drugs' potent actions on fundamental neurobiological systems. This chapter will provide a comprehensive examination of these mechanisms, drawing upon established research. We will explore the primary neurotransmitter systems affected, the neural circuits that mediate the psychological and physiological effects, and the cellular and molecular adaptations that occur. Furthermore, we will review neuroimaging findings that illuminate the structural and functional brain changes associated with stimulant use and discuss the neurodevelopmental implications of exposure. Finally, we will consider how this biological understanding informs the mechanisms of treatment for acute intoxication and shapes future directions for research in this critical area of neuropsychiatry.

## Neurobiological Systems

The profound psychophysiological effects of stimulant intoxication are rooted in the drugs' powerful disruption of several key neurobiological systems. As sympathomimetic agents, stimulants hijack and amplify the body's natural arousal and stress-response pathways, primarily through massive perturbation of monoamine neurotransmitter systems (Graddy & Rastegar, 2025; Williams et al., 2000). This leads to a state of global CNS and autonomic hyperexcitability that underlies both the desired euphoric effects and the potentially lethal toxicities (Winger et al., 2004; McCormack & Buckley, 2006).

### Neurotransmitter Systems and Neuropharmacology

The core mechanism of all major psychostimulants involves the acute enhancement of synaptic concentrations of the monoamine neurotransmitters: dopamine (DA), norepinephrine (NE), and serotonin (5-HT) (Varı̀ et al., 2018; Klega & Keehbauch, 2018). While individual stimulants have different primary targets and mechanisms, their overlapping effects on these three systems produce the characteristic toxidrome of intoxication (Williams et al., 2000; Varı̀ et al., 2018).

**The Dopaminergic System:** The dopamine system is fundamental to the reinforcing, locomotor, and psychotic effects of stimulants (Antonio & Alfredo, 2012; Beninger, 2018). The primary site of action is the mesocorticolimbic dopamine pathway, which projects from the ventral tegmental area (VTA) to the nucleus accumbens (NAc) and prefrontal cortex (PFC) (Antonio & Alfredo, 2012; Uddin et al., 2017). This circuit is a key mediator of reward, motivation, and goal-directed behavior (Beninger, 2018). Cocaine exerts its effects primarily by blocking the dopamine transporter (DAT), inhibiting the reuptake of DA from the synaptic cleft and thereby prolonging its action on postsynaptic receptors (Antonio & Alfredo, 2012; Klega & Keehbauch, 2018; Hall et al., 1990). Amphetamines, including methamphetamine, also block DAT but have the additional, more potent mechanism of entering the presynaptic terminal and promoting the release of DA from synaptic vesicles into the cytoplasm and then into the synapse via reverse transport through the DAT (Uddin et al., 2017; Klega & Keehbauch, 2018). This massive, non-physiological surge of synaptic DA is responsible for the intense euphoria ("high" or "rush"), increased energy, and heightened motivation associated with intoxication (Hurd, 1996; Antonio & Alfredo, 2012). This hyperdopaminergic state also drives the psychomotor activation, including hyperactivity, restlessness, and stereotyped, repetitive behaviors (punding) (Randrup et al., 1988; Hurd, 1996; Espay et al., 2015). At high levels of stimulation, this dopaminergic overactivity is strongly implicated in the development of paranoia, delusions, and hallucinations, producing a psychosis that can be clinically indistinguishable from paranoid schizophrenia (Snyder, 2019; Dore & Sweeting, 2006; Moncrieff, 2009; Morton, 1999).

**The Noradrenergic System:** The sympathomimetic and arousing effects of stimulants are largely mediated by their action on the noradrenergic system (Uddin et al., 2017; Bryan, 1990). Similar to their effects on dopamine, cocaine blocks the norepinephrine transporter (NET), while amphetamines both block NET and promote NE release (Klega & Keehbauch, 2018; Uddin et al., 2017). This leads to a dramatic increase in synaptic NE throughout the CNS and in the periphery. Centrally, this noradrenergic surge contributes to heightened alertness, vigilance, and focus (Winger et al., 2004). Peripherally, it results in profound activation of the sympathetic nervous system, causing the classic signs of intoxication such as tachycardia, hypertension, mydriasis (dilated pupils), and diaphoresis (sweating) (Williams et al., 2000; Graddy & Rastegar, 2025). This intense cardiovascular stimulation increases the risk of acute myocardial infarction, cardiac arrhythmias, and hypertensive emergencies that can lead to stroke (Ferdinand, 2000; Graddy & Rastegar, 2020; Meza-Ruiz & Zúñiga-Escobar, 2023). Furthermore, noradrenergic hyperactivity contributes to hyperthermia by increasing metabolic rate and causing peripheral vasoconstriction that impairs heat dissipation (Graddy & Rastegar, 2025; Williams et al., 2000). In the context of recurrent psychosis, noradrenergic hyperactivity has also been linked to stress sensitization, potentially lowering the threshold for future psychotic episodes (Yui et al., 2006).

**The Serotonergic System:** The serotonin (5-HT) system is also a critical target, particularly for substances like 3,4-methylenedioxymethamphetamine (MDMA, or "ecstasy") (Klega & Keehbauch, 2018). Cocaine blocks the serotonin transporter (SERT), while MDMA is a potent SERT inhibitor and 5-HT releasing agent (Klega & Keehbauch, 2018; de la Torre et al., 2004). The resulting increase in synaptic 5-HT contributes significantly to the mood-elevating, empathogenic, and prosocial effects sought by recreational users (Varı̀ et al., 2018; de la Torre et al., 2004). However, excessive serotonergic activity is fraught with danger. It can contribute to hyperthermia and, particularly when combined with other serotonergic agents like certain antidepressants, can precipitate serotonin syndrome (Scotton et al., 2019; McCormack & Buckley, 2006). Serotonin syndrome is a potentially fatal toxidrome characterized by a triad of mental status changes (agitation, confusion), autonomic hyperactivity (hyperthermia, tachycardia, diaphoresis), and neuromuscular abnormalities (tremor, clonus, hyperreflexia) (Scotton et al., 2019; Rahmani et al., 2011; Rastogi et al., 2011).

**Other Neurotransmitter Systems:** While monoamines are the primary mediators of acute intoxication, other systems are also involved. The brain's primary excitatory neurotransmitter, glutamate, and primary inhibitory neurotransmitter, γ-aminobutyric acid (GABA), are dysregulated during intoxication and play crucial roles in the downstream effects and long-term neuroplastic changes associated with addiction (Antonio & Alfredo, 2012). For example, stimulant-induced seizures reflect a shift in the balance towards excessive excitation, which can involve both increased glutamatergic activity and disruption of GABAergic inhibition (Zagnoni & Albano, 2002). Endogenous opioid peptide systems also interact with the dopamine system and may modulate the rewarding effects of stimulants (Hurd, 1996).

### Autonomic Nervous System and Hypothalamic-Pituitary-Adrenal (HPA) Axis

The clinical signs of stimulant intoxication reflect a state of massive autonomic nervous system arousal, specifically an overwhelming "fight-or-flight" sympathetic response (Graddy & Rastegar, 2025; Williams et al., 2000). The flood of norepinephrine and epinephrine into the circulation and at sympathetic nerve terminals directly stimulates adrenergic receptors on target organs (Bryan, 1990). This leads to increased heart rate, cardiac contractility, and blood pressure (Dünser & Hasibeder, 2009; Ferdinand, 2000). This adrenergic stress can become detrimental, leading to myocardial ischemia, tachyarrhythmias, and hypertensive crisis (Dünser & Hasibeder, 2009; Graddy & Rastegar, 2025; Post et al., 1974).

Stimulant use also potently activates the hypothalamic-pituitary-adrenal (HPA) axis, the body's primary neuroendocrine stress response system (Wand, 2008; Parrott, 2015). This activation leads to the release of corticotropin-releasing factor (CRF) from the hypothalamus, which in turn stimulates the pituitary to release adrenocorticotropic hormone (ACTH), and finally, the adrenal glands to release glucocorticoids like cortisol (Kehne, 2007). This hormonal cascade contributes to the state of arousal and metabolic mobilization during intoxication (Bryan, 1990). While this is an adaptive response to acute stress, chronic or repeated activation by stimulants can lead to dysregulation of the HPA axis, impairing the body's ability to manage stress and contributing to the negative affective states, such as anxiety and depression, that often follow intoxication and characterize withdrawal (Wand, 2008; Parrott, 2015).

In summary, the neurobiological state of stimulant intoxication is one of widespread neuronal and physiological hyperexcitability. It is driven by a drug-induced surge in monoamine neurotransmitters that powerfully activates CNS reward and arousal circuits, the sympathetic nervous system, and the HPA axis. This complex interplay of neurochemical and systemic effects accounts for the full spectrum of stimulant intoxication, from euphoria and increased energy to psychosis, cardiovascular collapse, and death.

## Genetic and Molecular Basis

While the acute pharmacological actions of stimulants on neurotransmitter systems are well-documented, the variability in individual responses—from mild euphoria to severe psychosis or medical crisis—suggests a complex interplay between the drug and underlying biological predispositions (Dore & Sweeting, 2006). This heterogeneity points to the significant roles of genetic factors and downstream molecular cascades in shaping the phenotype of stimulant intoxication. The transition from controlled use to compulsive use and the enduring neuroadaptations that characterize addiction also find their roots at the genetic and molecular level (Antonio & Alfredo, 2012).

### Genetic Factors and Heritability

The susceptibility to both initiating stimulant use and developing severe adverse reactions or a substance use disorder has a significant genetic component (Cadoret & Winokur, 1972). Although the specific genes related to the acute intoxication state are not well-defined in the available literature, research into related phenomena provides important clues. For instance, vulnerability to developing recurrent, stress-sensitized psychosis (flashbacks) after methamphetamine use has been linked to polymorphisms in dopamine receptor-encoding genes (Yui et al., 2006). Specifically, the DRD2 TaqIA A1/A1 genotype, which is associated with a reduced density of D2 receptors, has been identified as a potential factor influencing the risk of developing these long-term psychotic sequelae (Yui et al., 2006). This suggests that baseline differences in the constitution of the dopaminergic system can critically modulate an individual's response to stimulant-induced dopamine surges.

Furthermore, personality traits that predispose individuals to substance use, such as impulsivity and sensation-seeking, are known to be heritable and are linked to variations in monoaminergic systems (Batinić et al., 2017). Genetic factors may also influence the metabolism of stimulants, leading to higher or more sustained drug levels in some individuals and thereby increasing their risk for toxicity. While the provided literature does not detail specific metabolic gene variants, it is a recognized principle in pharmacogenetics that such variations can profoundly alter drug response and toxicity (Büttner, 2012). Therefore, it is reasonable to infer that an individual's genetic makeup contributes significantly to their risk of experiencing severe neuropsychiatric and medical complications during acute stimulant intoxication.

### Molecular and Cellular Mechanisms

The intense neurochemical barrage initiated by stimulants triggers a cascade of intracellular and molecular events that mediate both the acute effects of intoxication and the longer-lasting neuroplastic changes underlying addiction (Antonio & Alfredo, 2012; Kalivas, 2003).

**Transcription Factors and Gene Expression:** The acute effects of stimulants lead to rapid changes in the expression of immediate early genes, which in turn regulate the expression of other genes involved in neuronal function and structure (Yui et al., 2006). Over the longer term, repeated stimulant exposure induces more stable changes in transcription factors that orchestrate lasting neuroadaptations. Key among these are the cAMP response element-binding protein (CREB) and ΔFosB (Antonio & Alfredo, 2012). Activation of the CREB pathway is thought to mediate aspects of tolerance and dependence, contributing to the negative emotional state seen during withdrawal (Antonio & Alfredo, 2012). In contrast, the accumulation of the highly stable protein ΔFosB is believed to mediate long-term plasticity related to behavioral sensitization—the progressive augmentation of a behavioral response to the drug with repeated administration—and may contribute to the propensity for relapse (Antonio & Alfredo, 2012; Kalivas, 2003). Alterations in the expression of transcription factors have been noted in post-mortem studies of cocaine abusers, underscoring their relevance to the human condition (Büttner, 2012).

**Receptor and Transporter Adaptations:** The persistent overstimulation of monoamine receptors during intoxication and chronic use leads to compensatory adaptations. The brain attempts to restore homeostasis by altering the number and sensitivity of neurotransmitter receptors and transporters (Hall et al., 1990). For instance, chronic exposure to high levels of dopamine can lead to a downregulation of dopamine receptors, which may contribute to the anhedonia and dysphoria experienced after the acute effects of the drug wear off (Khantzian, 1985; Snyder, 2019). These receptor changes are a core component of tolerance, where progressively higher doses of the drug are needed to achieve the same effect, and also contribute to the withdrawal syndrome (Hall et al., 1990; Hughes et al., 1994).

**Oxidative Stress and Neurotoxicity:** The intense metabolic and neuronal activity spurred by stimulants can generate significant oxidative stress (Alfonso‐Loeches & Guerri, 2011). The metabolism of dopamine itself can produce reactive oxygen species, and this process is greatly amplified during the massive dopamine release caused by stimulants (Yui et al., 2006). This oxidative stress can damage cellular components, including lipids, proteins, and DNA, and impair mitochondrial function (Alfonso‐Loeches & Guerri, 2011). In severe or chronic cases, this can lead to neuronal damage and even cell death, a process known as neurotoxicity (Majewska, 1996; Büttner, 2012). This neurotoxic potential is particularly a concern with high-dose methamphetamine use and is thought to contribute to long-term cognitive impairments and an increased risk for neurodegenerative disorders like Parkinson's disease (Lappin & Sara, 2019; Yoshimura & Imai, 1990). The inflammatory response triggered by this cellular stress can further exacerbate neuronal injury (Herrera-Imbroda et al., 2023).

In conclusion, the biological response to stimulant intoxication extends far beyond simple receptor-level interactions. It involves a complex sequence of molecular events, governed by an individual's genetic predispositions, that alters gene expression, receptor function, and cellular health. These mechanisms not only define the acute experience of intoxication but also lay the groundwork for the persistent and destructive neuroadaptations that define stimulant use disorders.

## Brain Structure and Function

Stimulant intoxication profoundly alters brain function, and in cases of high-dose or chronic use, can lead to significant structural damage. The drugs' primary actions on core monoaminergic circuits produce the immediate functional changes characteristic of the intoxicated state, while the secondary physiological consequences, such as severe hypertension and vasoconstriction, can result in lasting neuropathological changes (Büttner, 2012; Meza-Ruiz & Zúñiga-Escobar, 2023).

### Brain Regions, Neural Circuits, and Functional Connectivity

The acute behavioral and psychological effects of stimulant intoxication are mediated by the functional alteration of specific, interconnected neural circuits (Antonio & Alfredo, 2012). As previously discussed, the central circuit is the mesocorticolimbic dopamine system, encompassing the VTA, NAc, and PFC (Uddin et al., 2017; Antonio & Alfredo, 2012). The surge of dopamine in the NAc is critical for the powerful reinforcing and euphoric properties of stimulants, driving the compulsive drug-seeking behavior that characterizes addiction (Beninger, 2018; Khantzian, 1985).

Simultaneously, increased dopamine and norepinephrine in the PFC disrupts executive functions, such as impulse control, decision-making, and working memory (Majewska, 1996; Antonio & Alfredo, 2012). This prefrontal dysregulation contributes to the poor judgment and risky behaviors often observed during intoxication (Lahey, 2021). In chronic users, this may manifest as a state of "hypofrontality," where baseline frontal lobe function is diminished, potentially predisposing them to impulsivity and relapse even during periods of abstinence (Majewska, 1996). Neurobiological research suggests this frontal dysfunction is a key component of stimulant addiction, viewing it as a neurological disorder (Majewska, 1996; Lepping et al., 2015).

The limbic system, particularly the amygdala and hippocampus, is also heavily involved. The amygdala processes emotional stimuli and is crucial for the anxiety, paranoia, and fear that can accompany high-dose intoxication (Antonio & Alfredo, 2012). The hippocampus, critical for memory formation, is involved in creating the powerful, long-lasting memories that associate drug use with specific cues (people, places, paraphernalia), which can later trigger intense craving and relapse (Beninger, 2018; Daley & Douaihy, 2019).

Motor circuits, including the basal ganglia (especially the striatum), are also highly activated, leading to the psychomotor stimulation, hyperactivity, and stereotyped movements (e.g., pacing, repetitive sorting, or grooming) seen during intoxication (Hurd, 1996; Randrup et al., 1988; Espay et al., 2015). These effects are a direct consequence of increased striatal dopamine levels (Randrup et al., 1988).

### Neuroimaging Findings

Neuroimaging studies in stimulant abusers have provided visual evidence of both the functional and structural consequences of drug use (Büttner, 2012). While ethical and practical constraints limit imaging during acute, severe intoxication in humans, studies of chronic users and data from post-mortem examinations inform our understanding of the potential damage.

**Structural Neuroimaging:** Structural magnetic resonance imaging (MRI) and computed tomography (CT) have revealed a range of abnormalities in individuals with a history of stimulant abuse. These include generalized cerebral atrophy (brain shrinkage), ventricular enlargement, and specific reductions in the volume of frontal and temporal lobe regions (Majewska, 1996; Büttner, 2012). A prominent and dangerous finding is evidence of cerebrovascular accidents. Both ischemic strokes (caused by blocked blood flow) and hemorrhagic strokes (caused by bleeding in or around the brain) are well-documented complications, visible on CT and MRI scans (Graddy & Rastegar, 2025; Meza-Ruiz & Zúñiga-Escobar, 2023; Lappin & Sara, 2019). These events are often a direct result of the acute hypertensive and vasoconstrictive effects of the drugs (Díez‐Tejedor et al., 1989; Ferdinand, 2000). Angiographic studies have sometimes shown evidence of cerebral vasculitis (inflammation of blood vessels) or reversible cerebral vasoconstriction syndrome (RCVS), which can precipitate these strokes (Díaz & Hernández, 2006; Büttner, 2012; Tsatsakis et al., 2019; Farooque et al., 2020). Furthermore, diffuse white matter lesions, indicative of toxic leukoencephalopathy, have been reported, reflecting damage to the brain's myelinated tracts (Kondziella et al., 2006; Majewska, 1996).

**Functional Neuroimaging:** Functional imaging techniques like positron emission tomography (PET) and single-photon emission computed tomography (SPECT) have been used to investigate brain activity and neurochemistry in stimulant users (Büttner, 2012). These studies have demonstrated alterations in cerebral blood flow and metabolism, particularly in frontal regions, consistent with the concept of hypofrontality (Majewska, 1996). They have also been used to show changes in the density and availability of dopamine transporters and receptors in chronic users, providing a neural correlate for the processes of tolerance and anhedonia (Hall et al., 1990).

### Neurological Complications of Intoxication

The massive neurochemical and physiological disruption of stimulant intoxication can precipitate a range of severe, acute neurological events (Díaz & Hernández, 2006; Karila et al., 2009).

**Seizures:** Stimulants are potent pro-convulsants that lower the seizure threshold (Zagnoni & Albano, 2002). Seizures can occur even in individuals without a history of epilepsy, particularly with high doses, "crack" cocaine use, or intravenous administration (Kramer et al., 1990; Koppel et al., 1996). The mechanism involves a state of neuronal hyperexcitability driven by increased monoaminergic and glutamatergic activity (Antonio & Alfredo, 2012; Zagnoni & Albano, 2002). Seizures are a common feature of severe intoxication and can contribute to other complications such as hyperthermia, rhabdomyolysis, and hypoxic brain injury (Graddy & Rastegar, 2025; Beebe & Walley, 1991).

**Stroke:** As noted, both ischemic and hemorrhagic strokes are among the most feared complications (Lappin & Sara, 2019; Tsatsakis et al., 2019). Ischemic strokes can result from vasospasm, vasculitis, or cardioembolism secondary to drug-induced arrhythmias or myocardial infarction (Büttner, 2012; Chitsaz, 2017). Hemorrhagic strokes, including intracerebral and subarachnoid hemorrhages, are often precipitated by a sudden, severe spike in blood pressure (Meza-Ruiz & Zúñiga-Escobar, 2023; Díez‐Tejedor et al., 1989). Individuals with underlying vascular anomalies, such as aneurysms, are at particularly high risk (Karila et al., 2009; Büttner, 2012).

**Movement Disorders:** The acute hyperdopaminergic state can induce a variety of movement disorders. These range from mild tremors and restlessness (akathisia) to more complex hyperkinetic phenomena such as chorea (rapid, jerky movements), dystonia (sustained muscle contractions causing abnormal postures), myoclonus, and stereotypies (Hurd, 1996; Catalano et al., 1997; Vasconcelos et al., 2022; Espay et al., 2015). While often transient and resolving as the drug is metabolized, these movement disorders can be distressing and, in the case of severe dystonia affecting respiratory muscles, potentially dangerous (Duma & Fung, 2019).

**Headache:** Headache is a very common neurological symptom associated with cocaine use, which can be a primary manifestation of the drug's vasoactive effects or a secondary symptom of a more severe underlying complication like hemorrhage or RCVS (Farooque et al., 2020; Karila et al., 2009; Díez‐Tejedor et al., 1989).

In essence, stimulant intoxication places the brain in a state of extreme functional stress, altering activity across critical circuits. This functional disturbance can, through a variety of mechanisms, translate into acute and potentially permanent structural damage, manifesting as a wide range of severe neurological complications.

## Developmental Neurobiology

The impact of stimulant intoxication on the brain is not uniform across the lifespan; the developing brain, particularly during adolescence, exhibits unique vulnerabilities to the effects of these substances (Nešpor, 2004). Adolescence is a critical period of neurodevelopment characterized by significant maturation of key brain circuits, including those involved in reward processing, impulse control, and executive function (Alfonso‐Loeches & Guerri, 2011). Exposure to potent psychoactive stimulants during this window can disrupt these developmental trajectories, with potential long-term consequences for mental health and behavior (Dubovický, 2010).

### Adolescent Vulnerability

Epidemiological data consistently show that initiation of stimulant use is most common during adolescence and young adulthood (Rastegar, 2020; Karila et al., 2014). This pattern of use coincides with a period when the brain, especially the prefrontal cortex (PFC), is still undergoing significant refinement (Alfonso‐Loeches & Guerri, 2011). The PFC is essential for top-down cognitive control, including decision-making, risk assessment, and inhibition of prepotent impulses (Majewska, 1996). The dopaminergic projections to the PFC are among the last to fully mature, a process that continues into the early twenties (Beninger, 2018).

Introducing a powerful dopaminergic agent like cocaine or amphetamine during this sensitive period can interfere with the normal pruning and strengthening of synaptic connections, potentially leading to a lasting deficit in executive functions (Nešpor, 2004; Alfonso‐Loeches & Guerri, 2011). The adolescent brain's reward systems are also thought to be hyper-responsive, while the PFC's inhibitory capacity is not yet fully developed. This imbalance may make adolescents more sensitive to the reinforcing effects of stimulants and more prone to impulsive, risky drug-taking behavior, thereby increasing the likelihood of developing a substance use disorder (Bari et al., 2010; Lahey, 2021). The cognitive and psychomotor impairments associated with acute intoxication may be more pronounced in this age group, contributing to poorer academic performance and an increased risk of accidents (Nešpor, 2004; Catheline, 2005).

### Prenatal Exposure and Long-Term Sequelae

While this chapter focuses on intoxication, it is relevant to note the developmental consequences of prenatal exposure to stimulants. Maternal use of substances like cocaine during pregnancy exposes the fetal brain to the drug, with potentially profound effects on neurodevelopment (Coles, 2003). Such exposure can interfere with fundamental processes like neurogenesis, cell migration, and synaptogenesis (Alfonso‐Loeches & Guerri, 2011). Children with prenatal cocaine exposure may exhibit a range of long-term neurobehavioral issues, including deficits in attention, executive function, and impulse control (Coles, 2003). These developmental impairments may, in turn, create a vulnerability to later substance use and psychiatric disorders, perpetuating a cycle of risk (Dubovický, 2010). The cognitive and behavioral problems can resemble those seen in attention-deficit/hyperactivity disorder (ADHD), suggesting a lasting impact on the brain's dopaminergic and noradrenergic systems (Coles, 2003).

### Critical Periods and Lasting Impact

The concept of critical or sensitive periods in development suggests that the timing of a neurological insult is crucial in determining its outcome (Dubovický, 2010). Exposure to stimulants during adolescence, a period of heightened neuroplasticity, may induce more profound and lasting changes than similar exposure in adulthood. These changes can alter the very architecture of the brain's motivational and cognitive control circuits, establishing a vulnerability that persists long after the acute intoxication has subsided (Alfonso‐Loeches & Guerri, 2011). This may manifest as an increased risk for a range of psychiatric conditions later in life, including not only substance use disorders but also mood and anxiety disorders and psychosis (Sommer & Arango, 2017; Nešpor, 2004). The interaction between stimulant use and environmental stressors during adolescence, such as trauma or social exclusion, can further amplify this risk, contributing to a trajectory of poor mental health outcomes (Wand, 2008; Sommer & Arango, 2017).

In summary, the neurobiological effects of stimulant intoxication are significantly modulated by the developmental stage of the brain. The adolescent brain's unique state of maturation renders it particularly susceptible to the disruptive influence of these drugs, increasing the risk for acute adverse events, the development of addiction, and the establishment of long-term neuropsychiatric vulnerabilities. Understanding these developmental factors is essential for creating effective prevention and intervention strategies targeted at this high-risk population.

## Treatment Mechanisms

The management of acute stimulant intoxication is a medical emergency that prioritizes the stabilization of vital functions and the control of severe behavioral and neurological manifestations (Sarkar et al., 2023; Monotti, 1993). As there are no specific antagonists to reverse the effects of stimulants like cocaine or amphetamines, treatment is primarily supportive and symptomatic (Fries et al., 2025). The biological rationale for these interventions is to counteract the profound CNS and sympathomimetic hyperactivity induced by the drug (McCormack & Buckley, 2006).

### Management of Agitation and Psychosis

Severe agitation, aggression, and psychosis are common and dangerous features of stimulant intoxication that require immediate intervention to ensure the safety of the patient and healthcare providers (Vilke & Ly, 2022; Morton, 1999).

**Benzodiazepines:** These agents are the cornerstone of treatment for stimulant-induced agitation and associated cardiovascular complications (McCormack & Buckley, 2006; Fries et al., 2025). Benzodiazepines, such as lorazepam or diazepam, act as positive allosteric modulators of the GABAA receptor, enhancing the inhibitory effects of the neurotransmitter GABA throughout the CNS (Thompson & Weber, 2021). This generalized CNS depression directly counteracts the hyperexcitable state driven by excessive monoamine release (Antonio & Alfredo, 2012). By increasing GABAergic tone, benzodiazepines effectively reduce agitation, sedate the patient, control seizures, and can also lower heart rate and blood pressure, thereby mitigating the sympathomimetic surge (Thompson & Weber, 2021; Sarkar et al., 2023).

**Antipsychotics:** When psychosis is prominent or agitation is refractory to benzodiazepines, antipsychotic medications may be employed (Fries et al., 2025; Correll et al., 2017). First-generation antipsychotics like haloperidol and second-generation agents like olanzapine or risperidone are used (Correll et al., 2017; Garza-Treviño, 1988). Their primary mechanism of therapeutic action in this context is the blockade of dopamine D2 receptors, which directly antagonizes the hyperdopaminergic state responsible for psychotic symptoms (Mailman & Murthy, 2010; Moncrieff, 2009). However, their use requires caution. Many antipsychotics can lower the seizure threshold, which is already reduced by the stimulant, and some can prolong the QTc interval on the electrocardiogram, increasing the risk of cardiac arrhythmias, a risk also present with stimulants themselves (Timour et al., 2012; Coleman, 2004). For this reason, combination therapy with a benzodiazepine is often recommended to allow for lower doses of the antipsychotic (Garza-Treviño, 1988).

### Management of Cardiovascular and Systemic Complications

The life-threatening medical complications of stimulant intoxication stem from intense sympathomimetic overstimulation (Graddy & Rastegar, 2025).

**Cardiovascular Support:** Management of severe hypertension and tachycardia is crucial to prevent myocardial infarction and stroke (Ferdinand, 2000). Benzodiazepines are first-line agents due to their ability to reduce central sympathetic outflow (McCormack & Buckley, 2006). For refractory hypertension, direct-acting vasodilators such as nitroglycerin may be used (Graddy & Rastegar, 2025). The use of pure beta-blockers (e.g., propranolol) is controversial and generally avoided in the context of cocaine intoxication, due to concerns about producing "unopposed alpha-adrenergic stimulation," which could paradoxically worsen hypertension and coronary vasoconstriction (Ferdinand, 2000; Bartels & Schacht, 2021). Labetalol, which has both alpha- and beta-blocking properties, may be a safer alternative if a beta-blocker is deemed necessary (DiGregorio, 1990).

**Hyperthermia Management:** Severe hyperthermia is a critical feature of stimulant toxicity, especially in cases of excited delirium, and is a major contributor to rhabdomyolysis, renal failure, and disseminated intravascular coagulation (Graddy & Rastegar, 2025; Shields et al., 2015; Beebe & Walley, 1991). The biological basis for treatment is aggressive and rapid external cooling (e.g., ice water immersion, cooling blankets) to reduce core body temperature and halt the cascade of temperature-dependent cellular injury (McCormack & Buckley, 2006). Sedation with benzodiazepines also helps by reducing psychomotor agitation and muscle hyperactivity, which are major sources of heat production (Fries et al., 2025).

**Seizure Management:** Stimulant-induced seizures are typically managed with intravenous benzodiazepines, which, as noted, enhance GABAergic inhibition and raise the seizure threshold (Sarkar et al., 2023; Zagnoni & Albano, 2002). If seizures are refractory, other anticonvulsants like barbiturates may be required (Thompson & Weber, 2021).

In conclusion, the biological basis of treatment for stimulant intoxication involves a multi-pronged approach aimed at reversing the state of global neuro-autonomic hyperactivity. This is achieved primarily by enhancing CNS inhibition with GABAergic agents like benzodiazepines, and, when necessary, directly antagonizing dopaminergic overactivity with antipsychotics, while providing aggressive supportive care to manage the systemic consequences of the sympathomimetic storm.

## Future Directions

Despite significant advances in understanding the clinical presentation and acute management of stimulant intoxication, the underlying biological and neurological mechanisms are still not fully elucidated. Much of the current knowledge is extrapolated from animal models, studies of chronic users, or post-mortem examinations, leaving gaps in our direct understanding of the dynamic processes occurring in the human brain during an acute intoxication episode (Antonio & Alfredo, 2012; Kalivas, 2003; Büttner, 2012). Future research must focus on bridging these gaps to develop more targeted and effective interventions.

A primary challenge and an urgent priority for future research is the burgeoning landscape of new psychoactive substances (NPS) (Varı̀ et al., 2018). Synthetic cathinones ("bath salts," "flakka") and novel amphetamine analogues are continually emerging, often with unknown pharmacological profiles and unpredictable toxicities (Salani et al., 2018; Albishri et al., 2023). While they are broadly classified as stimulants, their specific receptor affinities, metabolic pathways, and neurotoxic potential can differ significantly from classic stimulants like cocaine and methamphetamine (Hohmann et al., 2014). Research is critically needed to characterize the neuropharmacology of these novel agents to anticipate their clinical effects, develop specific detection methods, and guide emergency management (Varı̀ et al., 2018; Zawilska & Tomaszewska, 2019).

Another crucial avenue for investigation is the biological basis of individual vulnerability. It remains unclear why some individuals can use stimulants with relatively minor consequences, while others rapidly develop severe psychosis, life-threatening medical complications, or a persistent substance use disorder (Dore & Sweeting, 2006; Lappin & Sara, 2019). Future studies should integrate genetic, epigenetic, and developmental neurobiological approaches to identify biomarkers that predict adverse reactions. Identifying individuals with specific genetic polymorphisms in dopamine or serotonin pathways (Yui et al., 2006), or those with a history of early life stress that has altered HPA axis responsivity (Wand, 2008), could allow for targeted prevention and more vigilant monitoring.

The development of specific pharmacological treatments for stimulant intoxication represents a significant unmet need. Current management is supportive and symptomatic, relying on broad-acting CNS depressants like benzodiazepines (McCormack & Buckley, 2006). The development of specific antagonists or modulators that can selectively reverse the most dangerous effects of stimulants—without causing global sedation—would be a major therapeutic advance. This requires a deeper understanding of the specific receptor subtypes and downstream signaling pathways that mediate toxicity versus euphoria (Antonio & Alfredo, 2012). For example, targeting specific dopamine or glutamate receptor subtypes might allow for the selective attenuation of psychosis or seizures without completely blunting the reward pathways in a way that might precipitate severe dysphoria or withdrawal.

Advances in neuroimaging technology offer powerful tools to study the acute effects of stimulants in a controlled setting. While ethically complex, studies using techniques like functional magnetic resonance imaging (fMRI) or positron emission tomography (PET) could safely administer low doses of stimulants to human volunteers to map the real-time functional and neurochemical changes that define the intoxication state (Büttner, 2012). Such studies could validate findings from animal models and provide direct insights into the neural circuits underlying specific symptoms like paranoia, craving, or cognitive impairment, thereby identifying precise targets for intervention.

Finally, there is a need to better understand the transition from acute intoxication to the development of chronic neuropsychiatric sequelae. The mechanisms by which acute oxidative stress, inflammation, and excitotoxicity translate into lasting cognitive deficits, mood disorders, or an enduring vulnerability to psychosis are poorly understood (Majewska, 1996; Herrera-Imbroda et al., 2023). Longitudinal studies that follow individuals from their first exposures through the development of chronic use, employing both neuroimaging and molecular biomarkers, could illuminate the critical neuroplastic events that underpin this transition and suggest interventions to halt or reverse them.

## Conclusion

Stimulant intoxication represents a state of profound, drug-induced hyperactivation of the central and autonomic nervous systems. The biological and neurological underpinnings of this condition are centered on the massive, acute elevation of synaptic concentrations of the monoamine neurotransmitters—dopamine, norepinephrine, and serotonin (Varı̀ et al., 2018; Klega & Keehbauch, 2018; Antonio & Alfredo, 2012). This neurochemical surge, driven by the blockade of reuptake transporters and/or promotion of neurotransmitter release, powerfully engages the brain's core reward, arousal, and stress-response circuits (Uddin et al., 2017; Wand, 2008).

The functional consequences of this widespread neurobiological disruption are dose-dependent and account for the full spectrum of the clinical presentation (Wood et al., 2013). At lower doses, activation of the mesocorticolimbic dopamine system mediates the sought-after effects of euphoria, increased energy, and heightened motivation (Beninger, 2018). Concurrently, noradrenergic activation produces increased alertness and sympathetic arousal (Winger et al., 2004). However, with increasing dosage, this same neurochemical cascade becomes profoundly maladaptive. The hyperdopaminergic state can precipitate severe psychiatric disturbances, including agitation, paranoia, delirium, and a psychosis that can mimic schizophrenia (Vilke & Ly, 2022; Morton, 1999; Dore & Sweeting, 2006). The intense sympathomimetic drive places extreme stress on the cardiovascular system, leading to potentially fatal complications such as myocardial infarction, arrhythmia, and stroke (Graddy & Rastegar, 2025; Ferdinand, 2000; Meza-Ruiz & Zúñiga-Escobar, 2023). Neurological emergencies, including seizures and movement disorders, further reflect the state of CNS hyperexcitability (Zagnoni & Albano, 2002; Lappin & Sara, 2019).

The brain is not merely a passive recipient of these effects. Acute intoxication can trigger lasting neuroplastic changes and, in cases of high-dose or chronic use, can lead to structural damage, including cerebrovascular injury and neurotoxic cell loss (Büttner, 2012; Majewska, 1996). Vulnerability to these severe outcomes is shaped by a complex interplay of genetic predispositions, developmental factors, and environmental influences, highlighting the heterogeneity of the disorder (Lappin & Sara, 2019; Dubovický, 2010).

A clear understanding of this biological foundation is paramount for effective clinical management, which relies on symptomatically opposing the neuro-autonomic storm with CNS depress

## References

1. Abdo, C. H. N. (2017). Sexualidade e doenças reumáticas. Revista Paulista de Reumatologia. https://doi.org/10.46833/reumatologiasp.2017.16.3.6-12
2. Abe, Y., & Germai, A. (2012). Insomnia and Its Correlates: Current Concepts, Epidemiology, Pathophysiology and Future Remarks. InTech eBooks. https://doi.org/10.5772/36102
3. Abhilash, K. P., Jha, A., Bandhyopadhyay, R., & Victor, P. (2014). Hypoglycemia - A rare complication of carbamazepine overdose. Indian Journal of Pharmacology. https://doi.org/10.4103/0253-7613.144941
4. Aguiar, I. G., Gomes, S., Moreira, A. M., Henriques, V., & Silva, H. (2012). P-01 - Cafeinism and psychosis - when the habit becomes a threat. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)74168-8
5. Ahmed, S., & Paul, S. P. (2019). A Diagnostic Conundrum: Acute Intermittent Porphyria Coexisting with Lumbar Prolapsed Intervertebral Disc. Journal of College of Physicians And Surgeons Pakistan. https://doi.org/10.29271/jcpsp.2019.12.1236
6. Ajayi, O., Esangbedo, A., Lawal, A. A., Olanrewaju, A. O., Ojo, T. O., & Talabi, O. (2023). Moral Injury, Trance and Possession State or a Schizophrenic Illness. a Case report. BJPsych Open. https://doi.org/10.1192/bjo.2023.359
7. Albishri, S. B., Alotaibi, A. B., Alzoubaidi, F. M., & Elserafy, O. S. (2023). Flakka: “The Zombie Drug” A Medicolegal Concern: An Updated Review of α-Pyrrolidinopentiophenone. The Saudi Journal of Forensic Medicine and Sciences. https://doi.org/10.4103/sjfms.sjfms_7_23
8. Alfonso‐Loeches, S., & Guerri, C. (2011). Molecular and behavioral aspects of the actions of alcohol on the adult and developing brain. Critical Reviews in Clinical Laboratory Sciences. https://doi.org/10.3109/10408363.2011.580567
9. Ali, N., Rasheed, A., Tariq, I., Abdullah, F., Sarwar, A., Atta, R., & Qammer, Z. (2018). Adjunct Use of Low Dose Risperidone Verses Adjunct Use of Clonazepam with an SSRI in Treatment of Moderate to Severe Anxiety States; A Comparative Study. National Journal of Health Sciences. https://doi.org/10.21089/njhs.32.0051
10. Allen, R. E., & Kirby, K. A. (2012). Nocturnal leg cramps.. PubMed.
11. Alloy, L. B., & Abramson, L. Y. (2010). Cyclothymic Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0249
12. Amorim, M. J., Maurício, J., & Brandão, D. (2019). WHEN THE DISEASE ARISES FROM THE TREATMENT: CORTICOSTEROID-INDUCED PSYCHOSIS A CASE REPORT AND BRIEF LITERATURE REVIEW. https://doi.org/10.26226/morressier.5d1a037b57558b317a140b63
13. Andrade, C. (2004). Antidepressant-Withdrawal Mania. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v65n0716
14. Andrade, C. (2017). Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.17f11567
15. Anghelescu, G., Bojescu, A. A., Populeanu, R., Ionică, M., Vlădescu, M., Macovei, R. A., & Caragea, G. (2018). Multiple reactions monitoring for cocaine and ethylbenzoylecgonine to increase the signal/noise ratio in mass spectrometry analysis. Advanced Topics in Optoelectronics, Microelectronics, and Nanotechnologies IX. https://doi.org/10.1117/12.2322569
16. Anisman, H., Merali, Z., Poulter, M. O., & Hayley, S. (2005). Cytokines as a Precipitant of Depressive Illness: Animal and Human Studies. Current Pharmaceutical Design. https://doi.org/10.2174/1381612053381701
17. Antonio, E., & Alfredo, E. (2012). Cocaine Addiction: Changes in Excitatory and Inhibitory Neurotransmission. InTech eBooks. https://doi.org/10.5772/34410
18. Antón, R., Conde, L. A., Gardeazábal, M. B., Ozcariz, P. A., Zariquiey, N. C., Figueiredo, N. D. S., & Salinas, V. F. (2021). Cycloid psychosis. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.1702
19. Apovian, C. M., & Ness-Abramof, R. (2005). Drug-induced weight gain. Drugs of today. https://doi.org/10.1358/dot.2005.41.8.893630
20. Arpacı, A. H., Koç, A., Gürkan, Ö. E., Tosun, C., & Işık, B. (2017). Emergence Agitation or Excited Delirium. Gazi Medical Journal.
21. Arslaan, R. Z. (2020). Depression, COVID and migrants. Journal of Neonatal Biology.
22. Asadi, S. (2023). The Role of Bio- Psychological Factors in Sleep Anxiety and Hypomania Disorder. https://doi.org/10.31579/2835-2882/016
23. Asser, A., & Taba, P. (2015). Psychostimulants and Movement Disorders. Frontiers in Neurology. https://doi.org/10.3389/fneur.2015.00075
24. Av, S. (1990). [Psychomotor stimulants as agents for enhancing work capacity].. PubMed.
25. Ayala, L., Gómez‐Revuelta, M., Requena, C. M., Acilu, E. S. D. A. G. D., Olivares, O. P., Ruíz, M. J., Morales, N. N., Martin, M., Zufiaurre, M. L., Hernández, B., Itoiz, A. A., Peña, M., & González‐Pinto, A. (2017). Clozapine: Since the very beginning?. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.1402
26. Aydinak, S., Yalçın, C. Ö., & Abudayyak, M. (2018). Psychiatric Adverse Effects of Non-steroidal Analgesic Anti-inflammatory Drugs. Journal of Literature Pharmacy Sciences. https://doi.org/10.5336/pharmsci.2017-58076
27. Ayşe, H., Hakkı, ©., Arpacı, A. H., Koç, A., Gürkan, Ö. E., Tosun, C., & Işık, B. (2017). Emergence Agitation or Excited Delirium?. Gazi Medical Journal. https://doi.org/10.12996/gmj.2017.45
28. Bach, S. (2018). States of consciousness. Routledge eBooks. https://doi.org/10.4324/9780429471391-3
29. Backer, W. D. (2006). Obstructive Sleep Apnea-Hypopnea Syndrome. KARGER eBooks. https://doi.org/10.1159/000093150
30. Balvir, K. S., Dhanvij, B., Telrandhe, S., & Wajgi, R. D. (2021). A Case Report on Management of Subdural Hematoma. NVEO - NATURAL VOLATILES & ESSENTIAL OILS Journal | NVEO.
31. Banwari, G., Desai, P., & Patidar, P. (2015). Ketamine-induced affective switch in a patient with treatment-resistant depression. Indian Journal of Pharmacology. https://doi.org/10.4103/0253-7613.161277
32. Bari, A., Robbins, T. W., & Dalley, J. W. (2010). Impulsivity. Neuromethods. https://doi.org/10.1007/978-1-60761-934-5_14
33. Barnes, T. R. E., & Paton, C. (2011). Do antidepressants improve negative symptoms in schizophrenia?. BMJ. https://doi.org/10.1136/bmj.d3371
34. Bartels, K., & Schacht, J. P. (2021). Cocaine-Positive Patients Undergoing Elective Surgery: From Avoiding Case Cancellations to Treating Substance Use Disorders. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0000000000004969
35. Batinić, B., Duišin, D., & Vukosavljevic-Gvozden, T. (2017). Neurobiological bases for impulsive and compulsive behaviour: Implications for pharmacological and psychological interventions. Engrami. https://doi.org/10.5937/engrami1701017b
36. Batta, A., & Farid, B. (2011). Addiction in Adolescents ---- A Current Trend.
37. Baulac, M., & Laplane, D. (1990). [Alcohol and epilepsy].. PubMed.
38. Baum, R., & Campo, J. V. (2022). Medically Unexplained Symptoms. Pediatric Care Online. https://doi.org/10.1542/aap.ppcqr.396501
39. Baving, L., & Olbrich, H. M. (1996). Alcoholism and Depression. European Addiction Research. https://doi.org/10.1159/000259099
40. Bear, N., Blackmore, A. M., Blair, E., Gibson, N., Jalla, C., Langdon, K., Moshovis, L., Steer, K., & Wilson, A. (2016). Prevalence of symptoms associated with respiratory illness in children and young people with cerebral palsy. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.13016
41. Beebe, D. K., & Walley, E. (1991). Substance abuse: the designer drugs.. PubMed.
42. Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2009). Recommendation for a definition of acute symptomatic seizure. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02285.x
43. Belloeuf, L., Jeunne, C. L., & Hugues, F. C. (2000). [Paroxetine withdrawal syndrome].. PubMed.
44. Beninger, R. J. (2018). Life's rewards. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198824091.001.0001
45. Berg, A. T. (2011). Epilepsy, cognition, and behavior: The clinical picture. Epilepsia. https://doi.org/10.1111/j.1528-1167.2010.02905.x
46. Berger, K., & Carlson, B. (2010). Stimulering av örats akupunkter.
47. Bernstein, J. G. (1988). Psychotropic drug induced weight gain: mechanisms and management.. PubMed.
48. Bertodo, T. D. S., Gross, M. S., & Maldaner, E. B. (2018). TRANSTORNOS BIPOLAR E DEPRESSIVO: UMA REVISÃO DOS ASPECTOS CONCEITUAIS.
49. Biswas, D., Jamwal, A. S., Beniwal, A., Brar, T., & Saran, B. (2023). Treatment in obsessive–compulsive disorder. Santosh University Journal of Health Sciences. https://doi.org/10.4103/sujhs.sujhs_62_23
50. Bitnun, A., & Richardson, S. E. (2015). Childhood Encephalitis in Canada in 2015. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/2015/947602
51. Biyani, G., Vandana, S., & Bhatia, P. (2015). Opioids induced serotonin toxicity? Think again. Indian Journal of Anaesthesia. https://doi.org/10.4103/0019-5049.160979
52. Bjorvatn, B., Jernelöv, S., & Pallesen, S. (2021). Insomnia – A Heterogenic Disorder Often Comorbid With Psychological and Somatic Disorders and Diseases: A Narrative Review With Focus on Diagnostic and Treatment Challenges. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2021.639198
53. Black, D. W., Winokur, G., & Nasrallah, A. (1988). Depressions secondary to other psychiatric disorders and medical illnesses. American Journal of Psychiatry. https://doi.org/10.1176/ajp.145.2.233
54. Bolton, E., Holohan, D. R., King, L. A., & King, D. W. (2004). Acute and Post-Traumatic Stress Disorder. Routledge eBooks. https://doi.org/10.4324/9780203336960-13
55. Boughton, B. J. (1991). Hepatic and portal vein-thrombosis.. BMJ. https://doi.org/10.1136/bmj.302.6770.192
56. Bradic, L., Lokmić-Pekić, I., & Dzevad, B. (2018). Psychiatric comorbidity in patients with posttraumatic stress disorder and enduring personality change after catastrophic experience. https://doi.org/10.26226/morressier.5b68175cb56e9b005965c22b
57. Brashear, A., Sweadner, K. J., Cook, J., Swoboda, K. J., & Ozelius, L. J. (2014). ATP1A3-Related Neurologic Disorders. University of Washington, Seattle eBooks.
58. Brignole, M. (2006). Neurally mediated syncope. CRC Press eBooks. https://doi.org/10.1201/b13301-22
59. Brignole, M., Alboni, P., Benditt, D. G., Bergfeldt, L., Blanc, J., Thomsen, P. E. B., Dijk, J. G. V., Fitzpatrick, A., Hohnloser, S. H., Janousek, J., Kapoor, W. N., Kenny, R. A., Kułakowski, P., Masotti, G., Moyá, A., Raviele, A., Sutton, R., Theodorakis, G., Ungar, A., & Wieling, W. (2004). Guidelines on Management (diagnosis and treatment) of syncope ? update 2004. EP Europace. https://doi.org/10.1016/j.eupc.2004.08.008
60. Brock, K. A., Nguyen, B., Liu, N., Watkins, M., & Reutzel, T. J. (2005). The Use of Antidepressants in School-Age Children. The Journal of School Nursing. https://doi.org/10.1177/10598405050210060301
61. Brock, K. A., Nguyen, B., Liu, N., Watkins, M., & Reutzel, T. J. (2005). The Use of Antidepressants in School-Age Children. The Journal of School Nursing. https://doi.org/10.1622/1059-8405(2005)021[0318:tuoais]2.0.co;2
62. Brody, D. L. (2019). How Do You Make the Diagnosis of Concussion?. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190054793.003.0003
63. Brody, D. L. (2019). Mood Instability and Irritability. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190054793.003.0010
64. Brouwer, A., Carhart‐Harris, R., & Raison, C. L. (2023). Psychotomimetic Compensation and Sensitization. https://doi.org/10.31234/osf.io/y8dn2
65. Bryan, R. M. (1990). Cerebral blood flow and energy metabolism during stress. AJP Heart and Circulatory Physiology. https://doi.org/10.1152/ajpheart.1990.259.2.h269
66. Brădeanu, A. V., Tudor, R., Sîrbu, P. D., Ciubară, A., Pascu, L. S., & Ciubară, A. B. (2017). Alcohol Consumption – Implications in Orthopedic Trauma. American Journal of Psychiatry and Neuroscience. https://doi.org/10.11648/j.ajpn.s.2017050601.34
67. Budak, E. (2015). Alkol ve Madde Etkisi Altinda Araç Kullanimi ile İlişkili Psikolojik Faktörler Driving under the Influence of Alcohol and Substance and Related Psychological Factors.
68. Budak, E., & Taymur, İ. (2015). Psychological Factors related with Driving under the Influence of Alcohol and Substance Use. DergiPark (Istanbul University). https://doi.org/10.18863/pskguncel.133504
69. Budson, A. E., & Kensinger, E. A. (2023). What else can go wrong with your memory?. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780197607732.003.0014
70. Burk, A., Merchant, A., Rahman, H., Patel, A., Deshmukh, I., Merchant, R., Yam, A. A., Yu, A., Cai, C., Hassam, A., Le, D., & Lambroussis, C. G. (2025). Serotonin Syndrome Without Overdose: Polypharmacy-Induced Toxicity in a Medically Stable Young Adult. Cureus. https://doi.org/10.7759/cureus.86587
71. Burkhart, P. W. M. K. K. (2014). Drugs Highly Associated with Infusion Reactions Reported using Two Different Data-mining Methodologies. Journal of Blood Disorders & Transfusion. https://doi.org/10.4172/2155-9864.1000195
72. Burnett, M. S. (2015). Hyperkinetic Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190244927.003.0027
73. Bürk, K., Strelczyk, A., & Oertel, W. H. (2012). Intermittent Tunnel Vision in a Patient With Multiple Drug Abuse History. Movement Disorders. https://doi.org/10.1891/9781617050589.0090
74. Büttner, A. (2012). Neuropathological Alterations in Cocaine Abuse. Current Medicinal Chemistry. https://doi.org/10.2174/092986712803988947
75. Cacciapuoti, F., Capone, V., Crispo, S., Gottilla, R., Rocca, F. L., Esposito, M., & Mauro, C. (2025). Beyond the Broken Heart: Unusual Triggers of Stress Cardiomyopathy – A Narrative Review. Heart and Mind. https://doi.org/10.4103/hm.hm-d-24-00114
76. Cadoret, R. J., & Winokur, G. (1972). Genetic Principles in the Classification of Affective Illnesses. International Journal of Mental Health. https://doi.org/10.1080/00207411.1972.11448572
77. Calingasan, N. Y., Sheu, K. R., Baker, H., Gandy, S., & Gibson, G. E. (1996). Thiamine Deficiency as a Model of Selective Neurodegeneration with Chronic Oxidative Deficits. Neurodegenerative Diseases. https://doi.org/10.1007/978-1-4899-0209-2_25
78. Campling, F., & Sharpe, M. (2006). Managing Severe Anxiety, Panic or Depression. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198528821.003.0022
79. Cano‐Vindel, A., Miguel-Tobal, J. J., González, H. M., & Díez, I. I. (1994). El afrontamiento de la ansiedad en las drogodependencias. Anales de Psicología.
80. Capaldi, D. M., & Kim, H. K. (2014). Comorbidity of Depression and Conduct Disorder. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199797004.013.015
81. Capitani, E. M. D. (2009). Diagnóstico e tratamento da intoxicação por chumbo em crianças e adultos. Medicina (Ribeirão Preto). https://doi.org/10.11606/issn.2176-7262.v42i3p319-329
82. Caplan, R., Bursch, B., & Leipzig, A. (2012). Somatization. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199843824.003.0079
83. Caroff, S. N., Watson, C. B., & Rosenberg, H. (2021). Drug-induced Hyperthermic Syndromes in Psychiatry. Clinical Psychopharmacology and Neuroscience. https://doi.org/10.9758/cpn.2021.19.1.1
84. Carolei, A., & Ripa, P. (2015). Secondary headache in emergency. The Journal of Headache and Pain. https://doi.org/10.1186/1129-2377-16-s1-a27
85. Carrera, M. A. V., Correa, S. M. V., Prado, M. M. C., & Granados, K. P. M. (2019). Manejo de intoxicación por opioides. RECIMUNDO. https://doi.org/10.26820/recimundo/3.(4).diciembre.2019.494-510
86. Cassano, G. B., Toni, C., Petracca, A., Deltito, J., Benkert, O., Curtis, G., Hippius, H., Maier, W., Shera, D., & Klerman, G. L. (1994). Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo. European Neuropsychopharmacology. https://doi.org/10.1016/0924-977x(94)90314-x
87. Castillo-Villanueva, E., Coy, P. E. C., Shejet, F. O., Durán, E. T., & Cabrera, D. M. (2010). Evaluación de funciones cognitivas: atención y memoria en pacientes con trastorno de pánico. Salud Mental.
88. Catalano, G., Catalano, M. C., & Rodríguez, R. (1997). Dystonia Associated With Crack Cocaine Use. Southern Medical Journal. https://doi.org/10.1097/00007611-199710000-00017
89. Catheline, N. (2005). [Academic problems and school failure in adolescence].. PubMed.
90. Cerón-Apipilhuasco, A., Loría-Castellanos, J., & Gómez-Bañuelos, L. V. (2023). Intoxicaciones delictivas. Anales Médicos de la Asociación Médica del Centro Médico ABC. https://doi.org/10.24875/amh.m23000027
91. Charante, E. P. M. V., Richard, E., & Perry, M. (2022). [Forgetfulness].. PubMed.
92. Charles, A. (2012). Migraine is not primarily a vascular disorder. Cephalalgia. https://doi.org/10.1177/0333102412441717
93. Charlton, S. R. (2020). Psychology and Black History Month in the United States. Eye on Psi Chi Magazine. https://doi.org/10.24839/2164-9812.eye24.4.18
94. Chaudhry, H., Arshad, N., Niaz, S., Cheema, F., Iqbal, M., & Mufti, K. (2005). Fifteen-year follow-up of conversion disorder. International Psychiatry. https://doi.org/10.1192/s1749367600007517
95. Chauhan, R., Bhunal, S., Gupta, D., Kumar, R., & Sharma, T. (2020). TO STUDY CLINICAL PROFILE OF ACUTE CONFUSIONAL STATE IN A TERTIARY CARE HOSPITAL IN A HILLY AREA.. International Journal of Scientific Research. https://doi.org/10.36106/ijsr/0915904
96. Chaves, T. V. (2019). Through ketamine fields: pain and afterglow. https://doi.org/10.33612/diss.107955714
97. Chee, K. T., Sim, K., Lee, T. S., & Ng, B. Y. (2010). Making Sense of Kleptomania: Clinical Considerations. Proceedings of Singapore Healthcare. https://doi.org/10.1177/201010581001900403
98. Cheniaux, E., Anunciação, L., Landeira-Fernández, J., & Nardi, A. E. (2023). Mood or energy/activity symptoms in bipolar mania: which are the most informative?. Trends in Psychiatry and Psychotherapy. https://doi.org/10.47626/2237-6089-2022-0551
99. Chitsaz, A. (2017). Stroke And Substance Abuse. Advances in Bioscience and Clinical Medicine. https://doi.org/10.7575/aiac.abcmed.ca1.34
100. Cho, Y.-R., Kim, H.-W., Lee, J.-I., Yun, J.-S., Lee, J. S., & Woo, Y.-S. (2008). A Case of Fluoxetine Induced Mania in Poststroke Depression Patient -A case report-. Annals of Rehabilitation Medicine.
101. Chow, W., Khullar, A., Lalla, F., Lessard, S., Lowe, A., & McIntosh, D. (2025). Practical Recommendations for Hypnotic Switching in Insomnia Management: A Canadian Expert Clinical Framework. Canadian Primary Care Today. https://doi.org/10.58931/cpct.2025.3s0148
102. Chung, S., Oh, K., Cho, K., & Hwang, I.-K. (2003). Antidepressant-Induced Somnambulism：A Case of Mirtazapine. Sleep Medicine and Psychophysiology.
103. Coghill, D., Bonnar, S., Duke, S., Graham, J., & Seth, S. (2009). Obsessive compulsive disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199234998.003.0020
104. Cohen, J. A., Mowchun, J. J., Lawson, V. H., & Robbins, N. M. (2016). A 19-Year-Old Male with Stiffness and Weakness After Waking. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190491901.003.0026
105. Coleman, J. J. (2004). Drug-induced seizures. Adverse Drug Reaction Bulletin. https://doi.org/10.1097/00012995-200408000-00001
106. Coles, C. D. (2003). Individuals Affected by Fetal Alcohol Spectrum Disorder (FASD) and Their Families: Prevention, Intervention and Support.
107. Conway, K. P., Montoya, I. D., & Compton, W. M. (2007). Lifetime Psychiatric Comorbidity of Illicit Drug Use Disorders. The Psychiatric times.
108. Coronado, L. M. Q., Florez, D. A. C., & Tarazona, M. C. L. (2017). Prevalencia depresión en estudiantes universitarios Bucaramanga 2017.
109. Correia‐Melo, F. S., Silva, S. S., Araújo-de-Freitas, L., & Quarantini, L. C. (2017). S-(+)-ketamine-induced dissociative symptoms as a traumatic experience in patients with treatment-resistant depression. Brazilian Journal of Psychiatry. https://doi.org/10.1590/1516-4446-2016-2070
110. Correll, C. U., Yu, X., Xiang, Y., Kane, J. M., & Masand, P. S. (2017). Biological treatment of Acute Agitation Or Aggression with Schizophrenia Or Bipolar Disorder in the Inpatient Setting. Annals of Clinical Psychiatry. https://doi.org/10.1177/104012371702900203
111. Corruble, E., Warot, D., & Soubrie, C. (2003). Insomnia linked to medications. SLEEP. https://doi.org/10.1007/978-1-4615-0217-3_20
112. Cottencin, O., Danel, T., Goudemand, M., Thomas, P., & Consoli, S. M. (2009). Catatonia recognition and treatment.. PubMed.
113. Cousins, D. A., & Young, A. H. (2006). The armamentarium of treatments for bipolar disorder: a review of the literature. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145706007413
114. Couto, F. S. D., & Mendonça, A. D. (2010). Sintomas psiquiátricos e comportamentais da demência. Revista Portuguesa de Clínica Geral. https://doi.org/10.32385/rpmgf.v26i1.10713
115. Coutts, S. R., Smith, I., & Stirzaker, A. G. (2025). Clarithromycin-Induced Psychosis: When Is Delirium Not Delirium?. Cureus. https://doi.org/10.7759/cureus.93096
116. Cruz, A. S. (2012). P-1458 - Postpartum psychosis: a case report. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)75625-0
117. Cruz, M. C. D., Camargo, R. P. D., Cruz, L. C. D., Schiefelbein, N., Cruz, D. M. D., & Cruz, M. C. C. D. (2020). Migrânea: revisão de literatura. ARCHIVES OF HEALTH INVESTIGATION. https://doi.org/10.21270/archi.v10i2.4670
118. Cruz, S. L., & López, C. B. (2003). Fármacos que producen dependencia física y adicción. Avance y perspectiva.
119. Curto, M. P. M., & Quintana, M. V. M. (2009). [Co-morbility during depression].. PubMed.
120. Dailey, J., & Clementz, G. L. (1988). Psychotropic effects of caffeine.. PubMed.
121. Daley, D. C., & Douaihy, A. (2006). Medications in Dual Recovery. https://doi.org/10.1093/oso/9780195311297.003.0006
122. Daley, D. C., & Douaihy, A. (2006). The Recovery Process for Addiction and Mood Disorders. https://doi.org/10.1093/oso/9780195311297.003.0004
123. Daley, D. C., & Douaihy, A. (2006). Understanding Mood Disorders: Depression and Bipolar Illness. https://doi.org/10.1093/oso/9780195311297.003.0003
124. Daley, D. C., & Douaihy, A. (2019). Managing Cravings and Urges to Use Substances. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926717.003.0009
125. Daley, D. C., & Douaihy, A. (2019). Substance-Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0002
126. Daley, D. C., & Douaihy, A. (2019). Understanding Substance Use Problems. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926717.003.0002
127. Dalvi, A., Lyons, K. E., & Pahwa, R. (2006). Secondary Dystonia. CRC Press eBooks. https://doi.org/10.3109/9781420019988-19
128. Darriba, H. B. (2023). A complex polymorphous psychosis or a cycloid psychosis with a different onset?. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.2246
129. Das, C., & Joseph, S. (2005). Falls in elderly.. PubMed.
130. Dauner, A., & Blair, D. (1990). AKATHISIA: When Treatment Creates a Problem. Journal of Psychosocial Nursing and Mental Health Services. https://doi.org/10.3928/0279-3695-19901001-05
131. Davidson, K. W. (2008). Emotional predictors and behavioral triggers of acute coronary syndrome.. Cleveland Clinic Journal of Medicine. https://doi.org/10.3949/ccjm.75.suppl_2.s15
132. Delgado, Y. O., Reyes, A. C., & Imas, Y. A. (2012). Trastorno por estrés agudo: Presentación de un caso. Cuadernos de Medicina Forense. https://doi.org/10.4321/s1135-76062012000100004
133. DeLuca, G. C., & Bartleson, J. D. (2010). When and How to Investigate the Patient with Headache. Seminars in Neurology. https://doi.org/10.1055/s-0030-1249221
134. Dhingra, L., Ahmed, E., Shin, J. G., Scharaga, E., & Magun, M. (2015). Cognitive Effects and Sedation. Pain Medicine. https://doi.org/10.1111/pme.12912
135. Dias, R. D. S. (2010). Estudo comparativo do fenótipo clínico de mulheres com transtorno afetivo bipolar em fase reprodutiva da vida com e sem piora pré-menstrual do humor. https://doi.org/10.11606/t.5.2010.tde-28052010-101220
136. Domínguez, M. R., Burgos, L. M., & Bergink, V. (2020). Perinatal Mood and Anxiety Disorders. Obstetrics and gynecology.. https://doi.org/10.1002/9781119450047.ch16
137. Donghi, A., Maidana, M., Vázquez, L. G., & Rodríguez, R. O. (2011). DIAGNÓSTICO DIFERENCIAL (NEUROSIS-PSICOSIS) DEL MODO DE TRATAMIENTO DEL DOLOR EN CONSUMIDORES DE PASTA BASE DE COCAÍNA (PACO). III Congreso Internacional de Investigación y Práctica Profesional en Psicología XVIII Jornadas de Investigación Séptimo Encuentro de Investigadores en Psicología del MERCOSUR.
138. Dore, G., & Sweeting, M. (2006). Drug-Induced Psychosis Associated with Crystalline Methamphetamine. Australasian Psychiatry. https://doi.org/10.1080/j.1440-1665.2006.02252.x
139. Dore, G., & Sweeting, M. (2006). Drug-induced psychosis associated with crystalline methamphetamine. Australasian Psychiatry. https://doi.org/10.1111/j.1440-1665.2006.02252.x
140. Douglas, K. S. (2015). Addiction and Violence Risk. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp432
141. Drago, F., & Caraci, F. (2020). Faculty Opinions recommendation of Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review.. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature. https://doi.org/10.3410/f.733303213.793576054
142. Duarte, N. D. S., Corrêa, L. M. D. A., Assunção, L. R., Menezes, A. A. D., Castro, O. B. D., & Teixeira, L. F. (2017). Relation between Depression and Hormonal Dysregulation. Open Journal of Depression. https://doi.org/10.4236/ojd.2017.63005
143. Dube, S., & Babar, A. (2023). Stress and Insomnia – A Vicious Circle. Sustainability Agri Food and Environmental Research. https://doi.org/10.7770/safer-v13n2-art742
144. Dubovický, M. (2010). Neurobehavioral manifestations of developmental impairment of the brain. Interdisciplinary Toxicology. https://doi.org/10.2478/v10102-010-0012-4
145. Duffard, A. M. E. D., & Duffard, R. (1996). Behavioral toxicology, risk assessment, and chlorinated hydrocarbons.. Environmental Health Perspectives. https://doi.org/10.1289/ehp.96104s2353
146. Duits, N., & Bos, F. M. (1993). [Psychiatric disorders with use of simvastatin].. PubMed.
147. Duma, S., & Fung, V. S. (2019). Drug-induced movement disorders. Australian Prescriber. https://doi.org/10.18773/austprescr.2019.014
148. Durán, L. V. B., González, M., & Álvarez, G. B. (2020). Trastorno por estrés postrauma. Revista Medica Sinergia. https://doi.org/10.31434/rms.v5i9.568
149. Dåderman, A. M., & Lidberg, L. (1999). [Rohypnol should be classified as a narcotic].. PubMed.
150. Díaz, B. C., & Hernández, M. Á. T. (2006). Complicaciones neurológicas por cocaína. Adicciones.
151. Díez‐Tejedor, E., Tejada, J. H., & Frank, A. (1989). [Neurologic complications caused by use of cocaine, amphetamines and sympathomimetics].. PubMed.
152. Dünser, M. W., & Hasibeder, W. (2009). Sympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic Stress. Journal of Intensive Care Medicine. https://doi.org/10.1177/0885066609340519
153. Ebenezer, I. S. (2015). Affective Disorders 2: Bipolar Disorder. https://doi.org/10.1002/9781118385777.ch7
154. Ebenezer, I. S. (2015). Drug Abuse and Addiction. https://doi.org/10.1002/9781118385777.ch11
155. Echterhoff, W. (2000). Der Schock nach dem Crash - die auf der Strecke bleiben. Psychologische Hilfe nach Unfaellen.
156. Egger, C., Muehlbacher, M., Nickel, M., Geretsegger, C., & Stuppaeck, C. (2006). A review on hyponatremia associated with SSRIs, reboxetine and venlafaxine. International Journal of Psychiatry in Clinical Practice. https://doi.org/10.1080/13651500500410216
157. Ehlers, A., Harvey, A. G., & Bryant, R. A. (2012). Acute stress reactions. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0092
158. Emilien, G., Durlach, C., Minaker, K. L., Winblad, B., Gauthier, S., & Maloteaux, J. (2004). Behavioral and psychological impairments. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7842-5_9
159. Eskander, F. S. L., Hakim, K. Y. K., Ibrahim, D., & ElMallah, W. (2021). Incidence Of Post-Operative Delirium In Geriatric Patients Undergoing Hip Replacement Surgery Using Pre-Operative Haloperidol. QJM. https://doi.org/10.1093/qjmed/hcab086.109
160. Esmaeilpour, F., Iderapalli, M., & Ugoh, E. (2025). Effective Management of Ketamine-Induced Bladder Syndrome With Baclofen During Ketamine Detoxification: A Case Report. BJPsych Open. https://doi.org/10.1192/bjo.2025.10724
161. Espay, A. J., Chaná, P., González-Usigli, H., & LaFaver, K. (2015). Psychostimulants and movement disorders.
162. Espinosa‐Jovel, C., & Sobrino, F. (2017). Caffeine and headache: specific remarks. Neurología (English Edition). https://doi.org/10.1016/j.nrleng.2014.12.022
163. Esquiliano, G. R., Ramírez, I. M., Valdés, A. T., & Aguilar, C. A. T. (2004). Daño neurológico secundario a hipoxia isquemia perinatal. Archivos de neurociencias (México, D.F.).
164. Fachrudin, D. (2019). Episode Depresif Berat dengan Gejala Psikotik (Studi Kasus dalam Perspektif Psikologi dengan Pendekatan Teori Kognitif Beck). Tunas Medika Jurnal Kedokteran & Kesehatan.
165. Falk, A., Joseph, R., Smith, S., & Wilk, A. (2023). Mood and Anxiety Disorders: Major Depressive Disorder.. PubMed.
166. Fama, J. M., & Wilhelm, S. (2010). Obsessions. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0616
167. Farne, H., Norris-Cervetto, E., & Warbrick‐Smith, J. (2015). Blackout. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198716228.003.0009
168. Farooq, H., Mohammad, T., Farooq, A., & Mohammad, Q. (2019). Alcohol Withdrawal Mimicking Neuroleptic Malignant Syndrome. Cureus. https://doi.org/10.7759/cureus.4697
169. Farooque, U., Okorie, N., Kataria, S., Shah, S. F., & Bollampally, V. C. (2020). Cocaine-Induced Headache: A Review of Pathogenesis, Presentation, Diagnosis, and Management. Cureus. https://doi.org/10.7759/cureus.10128
170. Fatigoni, S., Fumi, G., & Roila, F. (2015). [Cancer-related fatigue].. PubMed. https://doi.org/10.1701/1740.18954
171. Ferdinand, K. C. (2000). Substance Abuse and Hypertension.. PubMed.
172. Ferro, J. M., & Bentes, C. (2006). Post-stroke epilepsy. Aging Health. https://doi.org/10.2217/1745509x.2.4.599
173. Fink, M. (2010). Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195365740.003.0011
174. Fink, M. (2010). Other Uses: Psychosis, Pregnancy, and Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195365740.003.0012
175. Finsterer, J., & Strobl, W. M. (2010). Presentation, Etiology, Diagnosis, and Management of Camptocormia. European Neurology. https://doi.org/10.1159/000314897
176. Fischer, S., & Ehlert, U. (2019). Psychoneuroendocrinology and Clinical Psychology. Clinical Psychology in Europe. https://doi.org/10.32872/cpe.v1i2.33030
177. Fisher, A. D., Bandini, E., Casale, H., & Maggi, M. (2011). Paraphilic Disorders: Diagnosis and Treatment. https://doi.org/10.1002/9781119963820.ch8
178. Forcén, F. E. (2015). Akathisia: Is Restlessness a Primary Condition or an Adverse Drug Effect? Keep a Discerning Eye out for This Adverse Effect of Antipsychotics and Other Drugs. Current psychiatry.
179. Francis, M. V. (2016). Migraine without Aura -Towards a New Definition. Journal of Headache & Pain Management. https://doi.org/10.4172/2472-1913.100008
180. Franjić, S. (2023). Post-Traumatic Stress Disorder Appears as a Traumatic Experience. https://doi.org/10.61440/jcpn.2023.v1.04
181. Freitas, D. F. D., Teixeira-Ribeiro, R., Bouça, J., Fernandes, N., Duarte, J., & Morgado, P. (2015). Metformin-induced Psychosis: a Case Report.. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)31423-1
182. Friedel, B. (1991). ARZNEIMITTEL UND STRASSENVERKEHR. Arzt und Auto.
183. Fries, A., Christ, M., Nickl, H., Spreer, M., Pilhatsch, M., & Petzold, J. (2025). The Diagnosis and Treatment of Stimulant-Related Emergencies.. PubMed. https://doi.org/10.3238/arztebl.m2025.0158
184. García, M. D. S., & Calderón, R. M. (2010). Síntomas no motores en la enfermedad de Parkinson y estimulación cerebral profunda. Revista de Neurología. https://doi.org/10.33588/rn.50s02.2009745
185. Garg, T., & Rawat, V. S. (2023). Trihexyphenidyl Use Disorder and Withdrawal Syndrome. Journal of Psychiatry Spectrum. https://doi.org/10.4103/jopsys.jopsys_12_23
186. Garza-Treviño, E. S. (1988). El manejo de urgencia de los cuadros psicóticos agudos. Salud Mental.
187. Gauci, S., Hosking, W., & Bruck, D. (2017). Narcolepsy, cataplexy, hypocretin and co-existing other health complaints: A review. Cogent Medicine. https://doi.org/10.1080/2331205x.2017.1312791
188. Geissler, K. (1990). [Does the pill have a psychotropic effect?].. PubMed.
189. Genazzani, A. D., Ricchieri, F., Lanzoni, C., Strucchi, C., & Jasonni, V. M. (2006). Diagnostic and Therapeutic Approach to Hypothalamic Amenorrhea. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1365.009
190. Gerancher, J. C. (1997). Cauda Equina Syndrome following a Single Spinal Administration of 5% Hyperbaric Lidocaine through a 25-gauge Whitacre Needle. Anesthesiology. https://doi.org/10.1097/00000542-199709000-00031
191. Ghaemi, S. N. (2018). Children. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199995486.003.0028
192. Giacomo, E. D., Moretti, F., Colmegna, F., & Clerici, M. (2023). Obsessive–compulsive disorder as the onset of bipolar disorder in adolescence. Bipolar Disorders. https://doi.org/10.1111/bdi.13373
193. Gj, D. (1990). Cocaine update: abuse and therapy.. PubMed.
194. GOEKE, J. E., Hagan, D., Goelzer, S. L., & Coursin, D. B. (1991). Lethal catatonia complicated by the development of neuroleptic malignant syndrome in a middle-aged female. Critical Care Medicine. https://doi.org/10.1097/00003246-199111000-00023
195. Golden, C. J., & Golden, Z. L. (2004). Traumatic Brain Injury. Routledge eBooks. https://doi.org/10.4324/9780203336960-19
196. Goldenberg, D. L. (2021). Persistent Medical Problems. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197575390.003.0007
197. Goldfeder, S., Scott, R., & Briggs, J. P. (2023). Forensic Assessments of Alcohol, Cannabis and Methamphetamine Intoxication in Cases of Violent Offending.. PubMed.
198. Goodwin, G. M. (2006). Depression and associated physical diseases and symptoms. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2006.8.2/mgoodwin
199. Gordon, M. F., & Leder, A. (2012). Serotonin Syndrome. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-835-5_18
200. Goyal, A., Pallavi, K., & Awasthy, A. K. (2023). Reemergence of Neurological Deficit with Hyponatremia—When Obvious Is Not True. Journal of Neuroanaesthesiology and Critical Care. https://doi.org/10.1055/s-0042-1758459
201. Graddy, R., & Rastegar, D. A. (2020). Stimulants. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197506172.003.0008
202. Graddy, R., & Rastegar, D. A. (2025). Stimulants. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197796207.003.0008
203. Granger, C. E., & Shelly, M. P. (1996). Stressing out, or outing stress?. European Journal of Anaesthesiology. https://doi.org/10.1097/00003643-199611000-00001
204. Grant, I., Sacktor, N., & McArthur, J. C. (2005). HIV neurocognitive disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198526100.003.0035
205. Grimmer, K., Larsen, T. M., & Kumar, S. (2004). Effectiveness of manipulation and mobilisation for headaches: an evidence-based systematic review. JBI Library of Systematic Reviews. https://doi.org/10.11124/jbisrir-2004-665
206. Griswold, K., Regno, P. A. D., & Berger, R. C. (2015). Recognition and Differential Diagnosis of Psychosis in Primary Care.. PubMed.
207. Group, M. T., Mackway‐Jones, K., Marsden, J., & Windle, J. (2006). Discriminator Dictionary. https://doi.org/10.1002/9780470757321.oth3
208. Guerdjikova, A. I., & McElroy, S. L. (2015). Kleptomania. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp147
209. Gusmão, C. M. D., Garcia, L. R., Jesuthasan, A., Muir, M., Paciorkowski, A. R., Mink, J. W., & Silveira‐Moriyama, L. (2020). <scp>Kinesigenic</scp> Triggers in Episodic Ataxia Type 1. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.13008
210. Guthrie, E., & Nayak, A. (2012). Medically unexplained symptoms.
211. Gómez, C. C. R., Serrano‐Dueñas, M., Bernal, O., Araoz, N., Farret, M. S., Aldinio, V., Montilla, V., & Micheli, F. (2017). A Multicenter Comparative Study of Impulse Control Disorder in Latin American Patients With Parkinson Disease. Clinical Neuropharmacology. https://doi.org/10.1097/wnf.0000000000000202
212. Güleç, H., Babayiğit, M., Kurtay, A., Şahap, M., Ulus, F., Tutal, Z. B., & Horasanlı, E. (2014). Seizure due to multiple drugs intoxication: a case report. Brazilian Journal of Anesthesiology (English Edition). https://doi.org/10.1016/j.bjane.2014.02.013
213. Hagberg, M. (1996). ABC of Work Related Disorders: Neck and arm disorders. BMJ. https://doi.org/10.1136/bmj.313.7054.419
214. Hakan, M., & Kemal, A. R. (2009). Sporcularda Durumluk ve Sürekli Kaygi Düzeylerinin Bazi Değişkenlere Göre İncelenmesi Examxination Of The Level Of State - Trial Anxiety Of Sportsmen According To Some Variables.
215. Hall, W., Talbert, R. L., & Ereshefsky, L. (1990). Cocaine Abuse and Its Treatment. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/j.1875-9114.1990.tb02550.x
216. Hammen, C. (2003). Mood Disorders. Handbook of Psychology. https://doi.org/10.1002/0471264385.wei0804
217. Harrison, M. J. (1996). Clinical Skills in Neurology.
218. Hasan, S., & D’Adamo, M. C. (2015). Episodic Ataxia Type 1.
219. Hatcher-Kay, C., & King, C. A. (2003). Depression and Suicide. Pediatrics in Review. https://doi.org/10.1542/pir.24-11-363
220. Hayley, A. C., Parrott, A. C., & Downey, L. A. (2017). Recreational stimulants, herbal, and spice cannabis: The core psychobiological processes that underlie their damaging effects. Human Psychopharmacology Clinical and Experimental. https://doi.org/10.1002/hup.2594
221. Hemmingsen, R., & Kramp, P. (1988). Delirium tremens and related clilnical states:| Psychopathology, cerebral pathophysiology and psychochemistry: A two‐component hypothesis concerning etiology and pathogenesis. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1988.tb08575.x
222. Henkin, R. I., & Abdelmeguid, M. (2020). Smell Loss and Onset of Phantosmia are Critical Aspects of Head Injury Cognition. The FASEB Journal. https://doi.org/10.1096/fasebj.2020.34.s1.02320
223. Henning, A., Kurtom, M., & Espiridion, E. D. (2019). A Case Study of Acute Stimulant-induced Psychosis. Cureus. https://doi.org/10.7759/cureus.4126
224. Hermle, L., Gouzoulis‐Mayfrank, E., & Spitzer, M. (1996). Halluzinogen-induzierte psychische Störungen. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-2007-996594
225. Herrera-Imbroda, J., Flores-López, M., Ruiz-Sastre, P., Sánchez-Lafuente, C. G., Bordallo-Aragón, A., Fonseca, F. R. D., & Mayoral, F. (2023). The Inflammatory Signals Associated with Psychosis: Impact of Comorbid Drug Abuse. Biomedicines. https://doi.org/10.3390/biomedicines11020454
226. Hillman, D. R., Carlucci, M., Charchaflieh, J., Cloward, T. V., Gali, B., Gay, P. C., Lyons, M. M., McNeill, M. M., Singh, M., Yılmaz, M., & Auckley, D. (2023). Society of Anesthesia and Sleep Medicine Position Paper on Patient Sleep During Hospitalization. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0000000000006395
227. Hirano, S., Ichikawa, Y., Sato, B., Takefuji, Y., & Satoh, F. (2023). Successful treatment of myalgic encephalomyelitis/chronic fatigue syndrome using hydrogen gas: four case reports. Medical Gas Research. https://doi.org/10.4103/2045-9912.385441
228. Hoehn‐Saric, R., Lipsey, J. R., & McLeod, D. R. (1990). Apathy and Indifference in Patients on Fluvoxamine. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199010000-00007
229. Hohmann, N., Mikus, G., & Czock, D. (2014). Effects and Risks Associated with Novel Psychoactive Substances. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2014.0139
230. Houdenhove, B. V., Pae, C., & Luyten, P. (2010). Chronic fatigue syndrome: is there a role for non-antidepressant pharmacotherapy?. Expert Opinion on Pharmacotherapy. https://doi.org/10.1517/14656560903487744
231. Housley, S. B., Patel, D., Nyabuto, E., & Reynolds, R. M. (2021). Spinal cord detethering without laminectomy or laminotomy. Surgical Neurology International. https://doi.org/10.25259/sni_942_2021
232. Howland, R. H. (2014). Psychotropic Medication Use:What Will It Do To My Liver?. Journal of Psychosocial Nursing and Mental Health Services. https://doi.org/10.3928/02793695-20140722-01
233. Hsieh, M. T., Peng, W., Wu, C., Ng, K., Cheng, C. Y., & Xu, H. (2010). None. Planta Medica. https://doi.org/10.1055/s-002-20741
234. Hudler, G. W., & Sinclair, W. A. (1988). Tree Declines: Four Concepts of Causality. Arboriculture & Urban Forestry. https://doi.org/10.48044/jauf.1988.009
235. Hughes, J. R., Higgins, S. T., & Bickel, W. K. (1994). Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. Addiction. https://doi.org/10.1111/j.1360-0443.1994.tb03744.x
236. Huis, K. (2014). Suvremeno liječenje paničnog poremećaja.
237. Hurd, Y. L. (1996). Cocaine Effects on Dopamine and Opioid Peptide Neural Systems: Implications for Human Cocaine Abuse. PsycEXTRA Dataset. https://doi.org/10.1037/e495672006-006
238. Hybels, C. F., Blazer, D. G., & Steffens, D. C. (2006). Partial remission. A common outcome in older adults treated for major depression.. PubMed.
239. Inmaculada, M., & Pérez, P. B. (2016). Neuronal and behavioural effects of social isolation in old age.
240. Is, B., Golovoda, A., Pneumaticos, S. G., & Vlamis, J. (2021). The effect of depression in hospitalization and rehabilitation of patients with spinal cord injury. Acta Orthopaedica Et Traumatologica Hellenica.
241. Ishizaki, A., Kubota, M., Fueki, N., Shinozaki, M., Kurata, K., Takei, M., & Sakamoto, K. (1993). [Long-term clinical course of sequelae in patients with neonatal anoxic encephalopathy resulting in profound mental retardation and motor disturbance].. PubMed.
242. Iversen, L. L., Iversen, S. D., Bloom, F. E., & Roth, R. H. (2009). Psychedelics. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195380538.003.0606
243. Jaffee, M. S., Broshek, D. K., & Svingos, A. M. (2023). Early Emotional Symptoms of Concussion. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190630119.003.0004
244. Jain, S., Goel, S., & Kapila, S. (2015). Clinical Evaluation Of Psychiatric Emergencies.
245. Jakl, M., Skořepa, P., & Horáček, J. M. (2016). IMPACT OF EXTREME PHYSICAL EXERCISE ON HUMAN BODY. Military Medical Science Letters. https://doi.org/10.31482/mmsl.2016.026
246. Jalal, B. (2018). The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug. Psychopharmacology. https://doi.org/10.1007/s00213-018-5042-1
247. Jargin, S. V. (2019). Some aspects of tobacco smoking in the context of alcohol drinking, hangover and mental health problems. International Journal of Psychiatry Research. https://doi.org/10.33545/26648962.2019.v1.i2a.10
248. Jeon, H. J. (2023). Clinical presentation, diagnosis, and treatment of sleep disorders in adolescents. Journal of Korean Medical Association. https://doi.org/10.5124/jkma.2023.66.4.258
249. Jj, D. L. G. M., Francos, D. D., Herrero, H., Al, R. M., & Gómez, L. (1989). [Seasonal variations in dexamethasone suppression test in psychiatric patients].. PubMed.
250. Johnson, B. A. (1990). Psychopharmacological effects of cannabis.. PubMed.
251. Jovanović, J., Lazaridis, K., & Stefanović, V. (2006). THEORETICAL APPROACHES TO PROBLEM OF OCCUPATIONAL STRESS. Acta Facultatis Medicae Naissensis.
252. Judd, L. L., Schettler, P. J., Brown, E. S., Wolkowitz, O. M., Sternberg, E. M., Bender, B. G., Bulloch, K., Cidlowski, J. A., Kloet, E. R. D., Fardet, L., Joëls, M., Leung, D. Y., McEwen, B. S., Roozendaal, B., Rossum, E. F. C. V., Ahn, J., Brown, D. W., Plitt, A., & Singh, G. (2014). Adverse Consequences of Glucocorticoid Medication: Psychological, Cognitive, and Behavioral Effects. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2014.13091264
253. Kalivas, P. W. (2003). Development and Expression of Behavioral Sensitization. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-343-9_9
254. Kamijima, K., & Otsubo, T. (2004). Neuropsychiatric Symptoms Related to Interferon Therapy.
255. Kane, J. M., & Mayerhoff, D. (1989). Do Negative Symptoms Respond to Pharmacological Treatment?. The British Journal of Psychiatry. https://doi.org/10.1192/s0007125000291630
256. Kapała, W., Kapała, A., & Wojtyła-Buciora, P. (2023). Psychoactive Substances and Selected Health Problems Related to Their Use. https://doi.org/10.2478/bgbl-2023-0036
257. Kaplan, H., Sadock, B. J., & Grebb, J. A. (1994). Kaplan and Sadock's synopsis of psychiatry : behavorial sciences, clinical psychiatry. Williams & Wilkins eBooks.
258. Karila, L., Lowenstein, W., Coscas, S., Benyamina, A., & Reynaud, M. (2009). [Complications of cocaine addiction].. PubMed.
259. Karila, L., Roux, P., Rolland, B., Benyamina, A., Reynaud, M., Aubin, H., & Lançon, C. (2014). Acute and Long-Term Effects of Cannabis Use: A Review. Current Pharmaceutical Design. https://doi.org/10.2174/13816128113199990620
260. Karssemeijer, E. G., Heijden, C. D. V. D., Wolters, T. L. C., Boekhorst, B. T., Avest, M. T., & Kramers, C. (2021). [Don't stop medication too abruptly: advice about the discontinuation of medication]..
261. Karssemeijer, E. G., Heijden, C. D. V. D., Wolters, T. L. C., Boekhorst, B. T., Avest, M. T., & Kramers, C. (2021). [Don't stop medication too abruptly: advice about the discontinuation of medication].. PubMed.
262. Kazamatsuri, H. (1994). [Symptomatology and diagnosis of manic-depressive illness].. PubMed.
263. Kazymova, N., Kharlamenkova, N. Y., & Nikitina, D. A. (2019). Severe life events and their psychological consequences: loss or threat of loss of nearest. Vestnik Kostroma State University Series Pedagogy Psychology Sociokinetics. https://doi.org/10.34216/2073-1426-2019-25-2-96-101
264. Kehne, J. H. (2007). The CRF1 Receptor, a Novel Target for the Treatment of Depression, Anxiety, and Stress-Related Disorders. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/187152707780619344
265. Kelly, F. D. (2010). Adjustment Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0015
266. Khadse, V. S. C. (2022). Free Papers Compiled. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.341792
267. Khantzian, E. J. (1985). The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. American Journal of Psychiatry. https://doi.org/10.1176/ajp.142.11.1259
268. Kim, G. S., Nunez, T., & Vargas, E. (2021). Omeprazole-induced Visual Hallucinations: A Case Report. Journal of Psychiatric Practice. https://doi.org/10.1097/pra.0000000000000575
269. Kim, H. A., Bisdorff, A., Bronstein, A. M., Lempert, T., Rossi-Izquierdo, M., Staab, J. P., Strupp, M., & Kim, J. (2019). Hemodynamic orthostatic dizziness/vertigo: Diagnostic criteria. Journal of Vestibular Research. https://doi.org/10.3233/ves-190655
270. Kircus, E., & Brillhart, B. (1990). Dealing with Substance Abuse Among People with Disabilities. Rehabilitation Nursing. https://doi.org/10.1002/j.2048-7940.1990.tb01487.x
271. Kirsch, J., Simeon, D., Berlin, H. A., & Hollander, E. (2015). Disruptive, Impulse Control, and Conduct Disorders: Intermittent Explosive Disorder, Kleptomania, and Pyromania. Psychiatry. https://doi.org/10.1002/9781118753378.ch70
272. Klaassen, T. (2021). Novel strategies to address disrupted sensing and signalling of satiety. https://doi.org/10.26481/dis.20210903tk
273. Klega, A. E., & Keehbauch, J. (2018). Stimulant and Designer Drug Use: Primary Care Management.. PubMed.
274. Klein, S. (2015). Autistic phenomena in neurotic patients 1. Routledge eBooks. https://doi.org/10.4324/9781315743882-10
275. Kloft, L., Monds, L. A., Blokland, A., Ramaekers, J. G., & Otgaar, H. (2021). Hazy memories in the courtroom: A review of alcohol and other drug effects on false memory and suggestibility. Neuroscience & Biobehavioral Reviews. https://doi.org/10.1016/j.neubiorev.2021.02.012
276. Knaap, M. S. V. D., Depienne, C., Sedel, F., & Abbink, T. E. M. (2015). CLCN2-Related Leukoencephalopathy.
277. Kobayashi, M., Randrup, A., & Sørensen, G. (1988). Stereotyped behaviour in animals induced by stimulant drugs or by a restricted cage environment: relation to disintegrated behaviour, brain dopamine and psychiatric disease.. PubMed.
278. Kobayashi, T., Hayakawa, S., Matsuda, M., Tsuchida, H., Haga, H., Tani, N., & Fukui, K. (1999). [Mental and physical symptoms in alcoholics after alcohol withdrawal--comparing with involutional melancholia patients].. PubMed.
279. Kokaçya, M. H., Çöpoğlu, Ü. S., Şahpolat, M., & Arı, M. (2015). A Case of Cannabis Use-Associated Psychotic Disorder Accompanied by Autoscopic Phenomena. Addicta The Turkish Journal on Addictions. https://doi.org/10.15805/addicta.2015.2.1.061e
280. Kondziella, D., Danielsen, E. R., & Arlien‐Soeborg, P. (2006). Fatal encephalopathy after an isolated overdose of cocaine. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2006.088955
281. Koo, S. K. (2018). Depression Status in Korea. Osong Public Health and Research Perspectives. https://doi.org/10.24171/j.phrp.2018.9.4.01
282. Koppel, B. S., Samkoff, L., & Daras, M. (1996). Relation of Cocaine Use to Seizures and Epilepsy. Epilepsia. https://doi.org/10.1111/j.1528-1157.1996.tb00041.x
283. Korff, M. V., & Simon, G. (1996). The Relationship Between Pain and Depression. The British Journal of Psychiatry. https://doi.org/10.1192/s0007125000298474
284. Kosinski, C. M., & Meincke, U. (2010). Therapie psychischer Störungen bei Morbus Parkinson. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0029-1245307
285. Kotade, K. B., Pandit, B. S., Gaware, V. M., Dolas, R. T., Dhamak, K. B., Somwanshi, S. B., Nikam, V. K., & Khadse, A. N. (2011). KNOWING DEPRESSION AND PHARMACOLOGICAL, NON-PHARMACOLOGICAL APPROACHES FOR ITS TREATMENT.
286. Koçak, Ö., & Koçak, S. (2023). Underrated Diagnosis: Prenatal Depression. Kafkas Journal of Medical Sciences. https://doi.org/10.5505/kjms.2023.21033
287. Kramer, L. D., Locke, G. E., Ogunyemi, A. O., & Nelson, L. (1990). Cocaine-Related Seizures in Adults. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.3109/00952999009001592
288. Krause, K., & Krause, J. (2006). Is Akathisia a Frequent Side Effect of Neuroleptics in Patients with Attention Deficit/Hyperactivity Disorder?. Anesthesia & Analgesia. https://doi.org/10.1213/01.ane.0000227213.55202.92
289. Kuboki, T., & Suematsu, H. (1994). [Panic disorder].. PubMed.
290. Kumar, G. P., Krishna, P. Y., Manisha, D., Singh, G., Khushboo, A., & Ps, M. (2015). ROLE OF MANAS BHAVA IN THE ETIOPATHOGENESIS OF AMLAPITTA IN CONTEXT OF HYPERACIDITY.
291. Kushida, C. A., Littner, M. R., Morgenthaler, T. I., Alessi, C., Bailey, D. R., Coleman, J., Friedman, L., Hirshkowitz, M., Kapen, S., Kramer, M., Lee‐Chiong, T., Loube, D. L., Owens, J., Pancer, J., & Wise, M. S. (2005). Practice Parameters for the Indications for Polysomnography and Related Procedures: An Update for 2005. SLEEP. https://doi.org/10.1093/sleep/28.4.499
292. Lader, M. (1999). 1. The Influence of Drugs upon Testimony. Medicine Science and the Law. https://doi.org/10.1177/002580249903900203
293. Lahey, B. B. (2021). Dimensions of Externalizing Problems. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197607909.003.0004
294. Lam, R. W. (2018). Associated clinical features. Depression. https://doi.org/10.1093/med/9780198804147.003.0005
295. Lam, R. W. (2018). Clinical features and diagnosis. Depression. https://doi.org/10.1093/med/9780198804147.003.0004
296. Lappin, J., & Sara, G. (2019). Psychostimulant use and the brain. Addiction. https://doi.org/10.1111/add.14708
297. Lara, D. R. (2010). Caffeine, Mental Health, and Psychiatric Disorders. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-2010-1378
298. Latt, N., Conigrave, K. M., Saunders, J. B., Marshall, E. J., & Nutt, D. (2009). Chapter 10 Other drugs. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199539338.003.0010
299. Lee, H., Kim, J., Lee, H.-S., Jo, Y.-H., Ko, J.-A., In, S., & Lee, J.-B. (2023). MS Fragmentation of ALD-52 with GC-MS and LC-QTOF. Korean Journal of Forensic Science. https://doi.org/10.53051/ksfs.2023.24.1.2
300. Lee, K., Bahk, W., Yoon, B.-H., Jon, D., Lee, S.-Y., Kim, M.-D., Nam, B., & Song, M. (2018). T116. CAFFEINE-INDUCED PSYCHIATRIC MANIFESTATIONS. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sby016.392
301. LEHMAN, M., Foster, C., & Keul, J. (1993). Overtraining in endurance athletes: a brief review. Medicine & Science in Sports & Exercise. https://doi.org/10.1249/00005768-199307000-00015
302. Lejoyeux, M., & Adès, J. (1993). [Psychiatric emergencies in acute alcoholic intoxication].. PubMed.
303. Leon, C. F. M. D., & Appels, A. (1989). The association between vital exhaustion, unstable angina, and future myocardial infarction. Steinkopff eBooks. https://doi.org/10.1007/978-3-662-09434-1_6
304. Lepping, P., Huber, M., & Freudenmann, R. W. (2015). How to approach delusional infestation. BMJ. https://doi.org/10.1136/bmj.h1328
305. Lhommée, E., Klinger, H., Thobois, S., Schmitt, E., Ardouin, C., Bichon, A., Kistner, A., Fraix, V., Xie, J., Kombo, M. A., Chabardès, S., Seigneuret, É., Benabid, A., Mertens, P., Polo, G., Carnicella, S., Quésada, J.-L., Bosson, J., Broussolle, E., ... Krack, P. (2012). Subthalamic stimulation in Parkinson’s disease: restoring the balance of motivated behaviours. Brain. https://doi.org/10.1093/brain/aws078
306. Lim, S., Wadia, P. M., Armstrong, M. J., Schenck, C. H., & Lang, A. E. (2015). Augmented Restless Legs Syndrome with Marked Hyperkinesias and Impulsive‐Compulsive Behaviors. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.12299
307. Llcms, L. C., Martins, P. R. C., Loures, É. N., Vitalino, A. R., Lotufo, C. C., & Onady, S. Y. (2017). ATAQUE ISQUÊMICO TRANSITÓRIO E ESTADO DE MAL EPILÉPTICO COMO MANIFESTAÇÕES DE INTOXICAÇÃO AGUDA E ABSTINÊNCIA POR CRACK E COCAÍNA.
308. Logan, B. K., & Couper, F. J. (2003). 3,4-Methylenedioxymethamphetamine - Effects on Human Performance and Behavior.. PubMed.
309. Lokominienė, R. K. (2020). Parkinsono liga ir kiti judėjimo sutrikimai SARS-COV-2 sukeltos pandemijos kontekste. Neurologijos seminarai. https://doi.org/10.29014/ns.2020.17
310. Macenski, C. L. (2021). Recurrent episodes of intense fear, shortness of breath, racing heart, and sweating. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197577479.003.0014
311. Macneil, C., Hasty, M., Conus, P., Berk, M., & Scott, J. (2009). Social rhythm regulation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511757389.008
312. Madan, A., Frueh, B. C., Fowler, J. C., Stomberg, S., Bradshaw, M. R., Kelly, K. R., Weinstein, B., Luttrell, M., Danner, S. G., & Beidel, D. C. (2020). “Operator syndrome”: A unique constellation of medical and behavioral health-care needs of military special operation forces. The International Journal of Psychiatry in Medicine. https://doi.org/10.1177/0091217420906659
313. Madrid, P. A., Grant, R., Reilly, M. J., & Redlener, N. B. (2006). Challenges in Meeting Immediate Emotional Needs: Short-term Impact of a Major Disaster on Children's Mental Health: Building Resiliency in the Aftermath of Hurricane Katrina. PEDIATRICS. https://doi.org/10.1542/peds.2006-0099u
314. Madruga, M. L. L. H., Melo, G. B., Martins, J. M., Aranha, R. E. L. D. B., Marinho, J. C. R. L., Alves, N. T., Estudo, E., Revisão, U., & Literatura, D. (2018). Estudo Eletroencefalográfico De Indivíduos Com Dor Crônica Decorrente Da Fibromialgia: Uma Revisão Da Literatura. Scientific Research and Reviews. https://doi.org/10.28933/srr-2018-06-28100
315. Mahato, T. K., Ojha, S. K., Singh, V., & Parihar, S. P. S. (2021). Addiction withdrawal syndrome: Needs medications, education, counselling &amp; support. World Journal of Advanced Research and Reviews. https://doi.org/10.30574/wjarr.2021.12.2.0573
316. Maiese, A., Gitto, L., dellAquila, M., Serinelli, S., & Bolino, G. (2015). Association Between The Intake Of Cocaine And A Strong Physical And Emotional Stress: A Case Report Of A Sudden Death. European Journal of Forensic Sciences. https://doi.org/10.5455/ejfs.189757
317. Mailman, R. B., & Murthy, V. (2010). Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?. Current Pharmaceutical Design. https://doi.org/10.2174/138161210790361461
318. Maio, V. D., & Maio, T. D. (2005). Excited Delirium Syndrome: Cause of Death and Prevention.
319. Maj, M. (2023). Understanding depression beyond the “mind‐body” dichotomy. World Psychiatry. https://doi.org/10.1002/wps.21142
320. Majewska, M. (1996). Cocaine Addiction as a Neurological Disorder: Implications for Treatment. PsycEXTRA Dataset. https://doi.org/10.1037/e495672006-002
321. Mandyam, M. C., & Ahuja, N. (2017). Ketamine-Induced Mania During Treatment for Complex Regional Pain Syndrome. Pain Medicine. https://doi.org/10.1093/pm/pnx061
322. Manica, A., Leães, C. G. S., Frey, B. N., & Juruena, M. F. (1999). The role of depression in coronary artery disease. Arquivos Brasileiros de Cardiologia. https://doi.org/10.1590/s0066-782x1999000800012
323. Maramis, M. M. (2009). Mengenal Gangguan Mood pada Perempuan.
324. Marcello, S., & Silverstein, S. M. (2010). Schizophrenia. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0820
325. Maremmani, I., Pacini, M., & Maremmani, A. G. I. (2023). Chronic Psychosis in Dual Disorder Heroin Use Disorder Patients. https://doi.org/10.1007/978-3-031-30093-6_4
326. Maremmani, I., Pacini, M., Lamanna, F., Pani, P., Perugi, G., Deltito, J., Salloum, I. M., & Akiskal, H. S. (2010). Mood Stabilizers in the Treatment of Substance Use Disorders. CNS Spectrums. https://doi.org/10.1017/s1092852900027346
327. Martins, B. A., Madureira, R. S., Freitas, R. C., & Guidoreni, C. G. (2017). Enxaqueca. Congresso Médico Acadêmico UniFOA.. https://doi.org/10.47385/cmedunifoa.451.4.2017
328. Martínez‐Castrillo, J. C., Vela, L., Val, J. D., & Alonso‐Cánovas, A. (2011). Nonmotor Disorders and Their Correlation With Dopamine. The Neurologist. https://doi.org/10.1097/nrl.0b013e318239669f
329. Marvanová, M. (2016). Drug-induced cognitive impairment: Effect of cardiovascular agents. Mental Health Clinician. https://doi.org/10.9740/mhc.2016.07.201
330. Mattson, R. H. (1990). Selection of Drugs for the Treatment of Epilepsy. Seminars in Neurology. https://doi.org/10.1055/s-2008-1063985
331. Mauri, M. C. (2016). Drug Induced Psychosis or Schizophrenia?. Dual Diagnosis Open Access. https://doi.org/10.21767/2472-5048.100011
332. Mauri, M., & Ramacciotti, D. (2006). Sintomi Psichici e Somatici dei Disturbi dell'Umore: razionali di terapia. Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology.
333. Maxwell, R. A., & Eckhardt, S. B. (1990). Imipramine. Drug Discovery. https://doi.org/10.1007/978-1-4612-0469-5_10
334. McCormack, D., & Buckley, N. A. (2006). Psychostimulant poisoning. Australian Prescriber. https://doi.org/10.18773/austprescr.2006.068
335. McIntyre, R. S., & Calabrese, J. R. (2019). Bipolar depression: the clinical characteristics and unmet needs of a complex disorder. Current Medical Research and Opinion. https://doi.org/10.1080/03007995.2019.1636017
336. McQuillan, R. (2020). Symptoms other than pain. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0065
337. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed.
338. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). Diagnóstico y tratamiento del insomnio en el adulto mayor.
339. Meeusen, R., Cutsem, J. V., & Roelands, B. (2020). Endurance exercise‐induced and mental fatigue and the brain. Experimental Physiology. https://doi.org/10.1113/ep088186
340. Mehdiratta, N., Kalita, S., & Hirsch, A. R. (2023). Generalized Restless Body Syndrome: A case of opioid withdrawal- induced restlessness extending beyond the legs. https://doi.org/10.14293/p2199-8442.1.sop-.ptttfx.v1
341. Menezes, M. C. D. C., Gonçalves, L. G. V., Chaves, S. C. D. S., Jaime, T. F. M., Oliveira, I. C. Z., Sobrinho, K. D. L., Oliveira, L. L. D., Araújo, J. V. L. D., Gurian, F. G., Soares, I. L. T., Nero, L. D., Pereira, P. H. D. O., Moraes, F. D. C., & Teixeira, G. P. (2023). MAIN CAUSES OF INTENTIONAL ACCIDENTS IN PEDIATRICS AND CLINICAL MANIFESTATIONS - LITERATURE REVIEW. International Journal of Health Science. https://doi.org/10.22533/at.ed.1593712308095
342. Mercês, T. M. D. (2019). Controle hidroeletrolítico e respostas cardiovasculares à injeção central de angII, carbacol e hiperosmolaridade plasmática em ratos com epilepsia induzida por pilocarpina.
343. Meza-Ruiz, W., & Zúñiga-Escobar, G. (2023). Hematoma cerebral intraparenquimatoso e intraventricular por cocaína: reporte de un caso. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272023000100064
344. Micó, J., Brea, M. R. M., Corrales, O. R., & Gibert‐Rahola, J. (1999). [Drug interactions of methadone with CNS-active agents].. PubMed.
345. Mihanović, M., Bodor, D., Kezić, S., Restek-Petrović, B., & Silić, A. (2009). Differential diagnosis of psychotropic side effects and symptoms and signs of psychiatric disorders.. PubMed.
346. Miller, M. W., Marx, B. P., & Keane, T. M. (2010). Posttraumatic Stress Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0699
347. Mirawati, D. K. (2018). Managing antiepileptic drug, Starting, Changing and Stopping AED’s.
348. Mizukami, K., Naito, Y., Yoshida, M., Nakanishi, T., & Koizumi, J. (1990). Mental Disorders Induced by Carbamazepine. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.1990.tb00441.x
349. Moncrieff, J. (2009). A Critique of the Dopamine Hypothesis of Schizophrenia and Psychosis. Harvard Review of Psychiatry. https://doi.org/10.1080/10673220902979896
350. Monotti, R. (1993). [Drug emergencies].. PubMed.
351. Moore, D. P., & Puri, B. K. (2012). Textbook of Clinical Neuropsychiatry and Behavioral Neuroscience 3E.
352. Morales, D. O. (2019). Muerte encefálica en pediatría..
353. Morin, A. K., Jarvis, C. I., & Lynch, A. M. (2006). Therapeutic Options for Sleep‐Maintenance and Sleep‐Onset Insomnia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1592/phco.27.1.89
354. Morton, W. A. (1999). Cocaine and Psychiatric Symptoms. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.v01n0403
355. Moshé, S. L., & Galanopoulou, A. S. (2018). Commentary on Schotte et al. “Development of temporal lobe epilepsy during maintenance electroconvulsive therapy: A case of human kindling?”. Epilepsia Open. https://doi.org/10.1002/epi4.12296
356. Murasaki, M., & Takahashi, A. (2005). Drug Induced Movement Disorders. Wiley eBooks. https://doi.org/10.1002/9780470753217
357. Mörike, K., & Gleiter, C. H. (2003). Arzneimittel und Fahrtüchtigkeit. Therapeutische Umschau. https://doi.org/10.1024/0040-5930.60.6.347
358. Naidoo, S. (2015). Managing stress in the dental environment.
359. Naidu, B. M. (2016). Drug Abuse in India. International journal of research in social sciences.
360. Nakayama, H., Mihara, S., Sakuma, H., Kitamura, D., & Higuchi, S. (2014). SY08-3 * CO-MORBIDITY OF INTERNET ADDICTION. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agu052.39
361. Nam, K.-J., Kim, Y. J., Lee, S. Y., Lee, J. G., Cho, Y. H., Lee, Y.-H., Choi, E., Tak, Y. J., Yi, D., Park, S., & Jeong, D.-W. (2013). A Case of Incidentally Discovered Subclinical Cushing Syndrome in a Patient with Chronic Fatigue and Anxiety. Korean Journal of Family Medicine. https://doi.org/10.4082/kjfm.2013.34.4.289
362. Neal, S., & Fields, K. B. (2010). Peripheral nerve entrapment and injury in the upper extremity.. PubMed.
363. Nehretskii, S. (2023). Interdisciplinary Forensic and Pharmaceutical, Organizational and Legal, Clinical and Pharmacological Study of Abuse of Psychoactive Substances. SSP Modern Pharmacy and Medicine. https://doi.org/10.53933/sspmpm.v3i1.85
364. Neufeld, K. J., Needham, D. M., Oh, E. S., Wilson, L. M., Nikooie, R., Zhang, A., Koneru, M., Balagani, A., Singu, S., Aldabain, L., & Robinson, K. A. (2019). Antipsychotics for the Prevention and Treatment of Delirium. https://doi.org/10.23970/ahrqepccer219
365. Nicolson, G. L., Nasralla, M. Y., Haier, J., & Nicolson, N. L. (1999). GULF WAR ILLNESSES: ROLE OF CHEMICAL, RADIOLOGICAL AND BIOLOGICAL EXPOSURES.
366. Nikić, P., Zidverc‐Trajkovic, J., Andrić, B., Milinković, M., & Stojimirović, B. (2009). Caffeine-withdrawal headache induced by hemodialysis. The Journal of Headache and Pain. https://doi.org/10.1007/s10194-009-0119-1
367. Nomoto, M. (1996). [Recent progress in development of psychotropic drugs (3)--Antiparkinsonian agents applied in the treatment of Parkinson's disease or are under investigation for patients or model animals].. PubMed.
368. Noriega, C. G., Rotondo, H., & Alarco, F. (2014). El shock cardiazólico y su relación a la catatonia experimental. Anales de la Facultad de Medicina. https://doi.org/10.15381/anales.v21i2.9744
369. Ojeda, B. S., Salazar, A., Dueñas, W. A. M., & Failde, I. (2011). El deterioro cognitivo: un factor a tener en cuenta en la evaluación e intervención de pacientes con dolor crónico. Revista de la Sociedad Española del Dolor.
370. Ojimba, C., Isidahome, E. E., Odenigbo, N., Umudi, O. D., & Olayinka, O. (2019). Catatonia in major depressive disorder: diagnostic dilemma. A case report. Journal of Psychology & Clinical Psychiatry. https://doi.org/10.15406/jpcpy.2019.10.00651
371. Olmos-López, A., Ibarra-Aguilar, J., Cornelio-Nieto, J. O., Ocaña-Hernández, L. A., Márquez-Amaya, M. A., Luna-López, N. A., Reséndiz-Aparicio, J. C., & Rodríguez‐Leyva, I. (2019). Clinical guideline: status epilepticus in children and adults. DELETED. https://doi.org/10.24875/rmn.m19000031
372. Olshansky, B., Feigofsky, S., & Cannom, D. S. (2018). Is it bradycardia or something else causing symptoms?. HeartRhythm Case Reports. https://doi.org/10.1016/j.hrcr.2018.09.011
373. Onda, K., Yukawa, T., Sakaue, M., Tsuboya, R., Inoue, E., & Someya, T. (2021). Withdrawal from long‐term use of caffeinated drinks can cause schizophrenia‐like symptoms: A case report. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.13199
374. Osterman, J. E., Erdos, B. Z., Oldham, M., & Ivkovic, A. (2010). Antidepressant Treatments in PTSD. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-435-7_7
375. Otahbachi, M., Çevik, C., Bagdure, S., & Nugent, K. (2010). Excited Delirium, Restraints, and Unexpected Death. American Journal of Forensic Medicine & Pathology. https://doi.org/10.1097/paf.0b013e3181d76cdd
376. Outhoff, K. (2016). Cognitive enhancement: a brief overview. South African Family Practice. https://doi.org/10.4102/safp.v58i1.4436
377. Pang, N. T. P., & Masiran, R. (2020). Mood disorder induced by prednisolone – an easily overlooked complication. Current Problems of Psychiatry. https://doi.org/10.2478/cpp-2020-0012
378. Papp, L. A., Klein, D. F., & Gorman, J. M. (1993). Carbon dioxide hypersensitivity, hyperventilation, and panic disorder. American Journal of Psychiatry. https://doi.org/10.1176/ajp.150.8.1149
379. Paredes, D. F. D., Farfán, J. C. P., Orellana, J. M. F., & Legarda, A. A. B. (2019). Trastorno disfórico premenstrual. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(1).enero.2019.199-217
380. Parrott, A. (2015). The Adverse Psychiatric Consequences of Recreational Stimulant Drugs Such as Methamphetamine, Cocaine, Ecstasy/mdma, and Mephedrone: a Unified Psychobiological Explanation.. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)30842-7
381. Pary, R., Lippmann, S., & Tobias, C. R. (1988). Depression and Alcoholism: Clinical Considerations in Management. Southern Medical Journal. https://doi.org/10.1097/00007611-198812000-00016
382. Patel, A. I., Yadav, A., Patel, A. B., & Vyas, A. J. (2023). Post Covid-19 Women Complications. Asian Journal of Nursing Education and Research. https://doi.org/10.52711/2349-2996.2023.00017
383. Patel, A., Moreland, T., Haq, F., Siddiqui, F., Mikul, M., Qadir, H., & Raza, S. (2011). Persistent Psychosis After a Single Ingestion of “Ecstasy” (MDMA). The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.11l01200
384. Pathak, M., & Brashear, A. (2009). Spasticity. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511575761.015
385. Patricia, G. C. C., AAngela, G.-M., & Marina, R.-A. (2017). Diagnostic and therapeutical challenges of late-onset psychosis.. Journal of Psychology and Cognition. https://doi.org/10.35841/psychology-cognition.2.4.218-220
386. Patti, L., & Gupta, M. (2019). Change In Mental Status. StatPearls.
387. Paulus, W. J., Reimers, C. D., & Steinhoff, B. J. (2000). Dystonien (unwillkürliche Muskelbewegungen). Steinkopff eBooks. https://doi.org/10.1007/978-3-642-57726-0_16
388. Pechnick, R. N., Cunningham, K. A., & Danovitch, I. (2014). Hallucinogen-Related Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg51
389. Peduto, V. A., D'Uva, R., & Piga, M. (1996). [Carbamate and organophosphate poisoning].. PubMed.
390. Peiris, A. N., Jaroudi, S., & Noor, R. (2017). Heat Stroke. JAMA. https://doi.org/10.1001/jama.2017.18780
391. Pendergraft, W. F., Herlitz, L., Thornley‐Brown, D., Rosner, M. H., & Niles, J. L. (2014). Nephrotoxic Effects of Common and Emerging Drugs of Abuse. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.00360114
392. Penninx, B. W. (2021). Psychiatric symptoms and cognitive impairment in “Long <scp>COVID</scp> ”: the relevance of immunopsychiatry. World Psychiatry. https://doi.org/10.1002/wps.20913
393. Pergolizzi, J. V., Coluzzi, F., Varrassi, G., Mariano, D. J., LeQuang, J. A., Bisney, J., & Magnusson, P. (2019). Red wine triggers may lead to better understanding of migraine headache: a narrative review. Journal of Wine Research. https://doi.org/10.1080/09571264.2019.1573360
394. Perrott, J., & Burry, L. (2015). Has the Drug of Choice for Treating Critical Illness Delirium Been Established?. The Canadian Journal of Hospital Pharmacy. https://doi.org/10.4212/cjhp.v68i5.1494
395. Petit, J., & Sansone, R. A. (2011). A Case of Interdose Discontinuation Symptoms With Venlafaxine Extended Release. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.11l01140
396. Petkar, S., Jackson, M., & Fitzpatrick, A. (2005). Management of blackouts and misdiagnosis of epilepsy and falls. Clinical Medicine. https://doi.org/10.7861/clinmedicine.5-5-514
397. Phu, T., Remmers, A., Schytz, H. W., Schankin, C. J., Nelson, S. E., Obermann, M., Hansen, J. M., Sinclair, A. J., Gantenbein, A. R., & Schoonman, G. (2018). Red and orange flags for secondary headaches in clinical practice. Neurology. https://doi.org/10.1212/wnl.0000000000006697
398. Piccolo, A. C., Campos, L. M. G., & Audi, M. (2025). RELAÇÃO ENTRE A QUALIDADE DO SONO, PERCEPÇÃO CORPORAL E OS SINTOMAS MOTORES E SENSITIVOS EM PESSOAS COM ESCLEROSE MÚLTIPLA REMITENTE-RECORRENTE. Aracê.. https://doi.org/10.56238/arev7n8-002
399. Pich, E. M., Heidbreder, C., Mugnaini, M., & Teneggi, V. (2003). Molecular and Behavioral Aspects of Nicotine Dependence and Reward. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-343-9_16
400. Piróg-Balcerzak, A., Habrat, B., & Mierzejewski, P. (2015). Misuse and abuse of quetiapine. Psychiatria Polska. https://doi.org/10.12740/pp/32923
401. Politis, M., Wu, K., Molloy, S., Bain, P. G., Chaudhuri, К. R., & Piccini, P. (2010). Parkinson's disease symptoms: The patient's perspective. Movement Disorders. https://doi.org/10.1002/mds.23135
402. Pomerleau, C. S. (1997). Co‐factors for smoking and evolutionary psychobiology. Addiction. https://doi.org/10.1111/j.1360-0443.1997.tb03371.x
403. Poornima, S. (2018). Psychology Case Record.
404. Popa, T., & Delcea, C. (2019). Voyeurism and Scopophilia. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.11.121
405. Porcelli, P., Laera, D., Mastrangelo, D., & Masi, A. D. (2012). Prevalence of Allostatic Overload Syndrome in Patients with Chronic Cardiovascular Disease. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000341179
406. Porter, K. A., Porcari, C., Koch, E. I., Fons, C. E., & Spates, C. R. (2006). In vivo exposure treatment for agoraphobia.. The Behavior Analyst Today. https://doi.org/10.1037/h0100161
407. Post, R. M., Kotin, J., & Goodwin, F. K. (1974). The Effects of Cocaine on Depressed Patients. American Journal of Psychiatry. https://doi.org/10.1176/ajp.131.5.511
408. Prabha, Y. S. (2023). Stress as a Topic of Concern in Gut Health: A Review. UTTAR PRADESH JOURNAL OF ZOOLOGY. https://doi.org/10.56557/upjoz/2023/v44i123527
409. Pérez, J. M. C. (2003). Clínica de la adicción a pasta base de cocaína. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272003000100007
410. Pérez-Romero, J. L., Hernández‐Fernández, F., Moratalla, A. B. P., Ayo‐Martín, Ó., & Rubio, M. E. O. (2010). Síncopes de Repetición como presentación de Encefalopatía de Wernicke-Korsakov. Revista Clínica de Medicina de Familia. https://doi.org/10.4321/s1699-695x2010000200017
411. Pérez‐Riera, A. R., Barbosa‐Barros, R., Raimundo, R. D., & Abreu, L. C. D. (2017). Main artifacts in electrocardiography. Annals of Noninvasive Electrocardiology. https://doi.org/10.1111/anec.12494
412. Qamar, A., Kotha, K., & Ioachimescu, O. C. (2011). Obstructive Sleep Apnea. BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/978160805267711101010021
413. Qavi, A. H., Assad, S., Shabbir, W., Kundi, M., Habib, M., Babar, S., & Zahid, M. (2017). Cardiovascular Dysfunction Presenting as Autonomic Dysreflexia in a Patient with Spinal Cord Injury. Cureus. https://doi.org/10.7759/cureus.1456
414. Rahmani, M., Ahmadi, S., & Moghaddam, H. H. (2011). Serotonin Syndrome Following Single Ingestion of High Dose.
415. Rahmani, S. H. (2011). Serotonin Syndrome Following Single Ingestion of High Dose Methamphetamine. Journal of Clinical Toxicology. https://doi.org/10.4172/2161-0495.1000111
416. Rani, S., & Saini, D. S. (2015). Organizational Stress in Relation to Job Satisfaction and General Health of Professional Women. International journal of education and management studies.
417. Rascol, O., Payoux, P., Ory, F., Ferreira, J. J., Brefel‐Courbon, C., & Montastruc, J. (2003). Limitations of current Parkinson's disease therapy. Annals of Neurology. https://doi.org/10.1002/ana.10513
418. Rasmussen, K. G., & Ritter, M. J. (2014). Some Considerations of the Tolerability of Ketamine for ECT Anesthesia. Journal of Ect. https://doi.org/10.1097/yct.0000000000000100
419. Rastegar, D. A. (2020). Hallucinogens and Dissociatives. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197506172.003.0009
420. Rastogi, R., Swarm, R. A., Patel, T., & Riou, B. (2011). Case Scenario: Opioid Association with Serotonin Syndrome. Anesthesiology. https://doi.org/10.1097/aln.0b013e31823940c0
421. Resch, M. (2010). The psychological factors affecting athletic performance. Orvosi Hetilap. https://doi.org/10.1556/oh.2010.28890
422. Reynolds, E., & Wilson, J. V. K. (2014). Neurology and psychiatry in Babylon. Brain. https://doi.org/10.1093/brain/awu192
423. Richter, W., & Otto, C. (1997). [Hypoglycemia. Symptoms, differential diagnosis, therapy].. PubMed.
424. Riddle, M. A., King, R. A., Hardin, M. T., Scahill, L. D., Ort, S. I., Chappell, P., Rasmusson, A. M., & Leckman, J. F. (1990). Behavioral Side Effects of Fluoxetine in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.1990.1.193
425. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2012.0227
426. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.3917/rne.043.0196
427. Riverón-Carralero, W. J., Rondón-Vázquez, A. F., & Gómez, O. G. (2020). Coma hipopotasémico: a propósito de un caso. Universidad Médica Pinareña.
428. Rj, H., & Wr, S. (1994). Suspected endotoxin poisoning in two intravenous methamphetamine users.. PubMed.
429. Roberts, A. R., & Yeager, K. R. (2009). Indicators of a Crisis-Prone Person. https://doi.org/10.1093/oso/9780195382907.003.0004
430. Roberts, A. R., & Yeager, K. R. (2009). Stress Symptomatology and the General Adaptation Syndrome. https://doi.org/10.1093/oso/9780195382907.003.0008
431. Rodríguez, E. O., Martı́nez-Raga, J., Gómez, M. C., Gálvez, B. P., Ferragut, A. S., & Martínez, G. C. (2003). Complicaciones físicas del consumo de drogas recreativas. Adicciones. https://doi.org/10.20882/adicciones.462
432. Romero‐Sandoval, E. A. (2011). Depression and Pain. Anesthesiology. https://doi.org/10.1097/aln.0b013e31822ec185
433. Ronad, S. V., Patail, C. S., Gondbal, S. H., TC, K., Ronad, M., Pankaja, T., Badesgol, R., & Singhal, P. K. J. (2019). Professionals in metro cities suffer from anxiety disorder. Nursing & Care Open Access Journal. https://doi.org/10.15406/ncoaj.2019.06.00198
434. Ross, D. L., & Hazlett, M. H. (2018). Assessing the symptoms associated with excited delirium syndrome and the use of conducted energy weapons. Forensic Research & Criminology International Journal. https://doi.org/10.15406/frcij.2018.06.00206
435. Roy‐Byrne, P. (2015). Treatment-refractory anxiety; definition, risk factors, and treatment challenges. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2015.17.2/proybyrne
436. Ruiz, C. B., Torralbo, M. B., Garcia, R. R., Llobet, A. H., Fernández, I. A., Nielsen, N. P., Landeo, A. R., Ramírez, M. M., Fuentes, D. G., Soler, M. A., & Cañete, J. (2020). Psicosis dual y cariprazina. Caso clínico. LIBRO COMUNICACIONES. https://doi.org/10.17579/sepd2020p141
437. Ružić, M. (2016). Poremećaj glasa kod osoba treće životne dobi.
438. Sadiq, H., & Abakah, S. (2015). Depression and Its Relation with Blood Group According Differences (Sex).
439. Sagiv, N. (2004). Synesthesia in Perspective. https://doi.org/10.1093/oso/9780195166231.003.0001
440. Salani, D., Albuja, L. D., & Zdanowicz, M. M. (2018). The Explosion of a New Designer Drug, Flakka. Journal of Addictions Nursing. https://doi.org/10.1097/jan.0000000000000252
441. Salaspuro, M. (2009). [Intoxicated patient at the emergency department and referral to treatment].. PubMed.
442. Sardesai, A., Muneshwar, K. N., Bhardwaj, M., & Goel, D. B. (2023). The Importance of Early Diagnosis of Somatic Symptom Disorder: A Case Report. Cureus. https://doi.org/10.7759/cureus.44554
443. Sarkar, S., Bhatia, G., & Dhawan, A. (2023). Clinical Practice Guidelines for Assessment and Management of Patients with Substance Intoxication Presenting to the Emergency Department. Indian Journal of Psychiatry. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_490_22
444. Sato, S. (2018). Reconsidering the term ‘disinhibition’ in selective serotonin reuptake inhibitors‐induced apathy syndrome. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.12678
445. Schenck, C. H. (2003). Assessment and Management of Insomnia. JAMA. https://doi.org/10.1001/jama.289.19.2475
446. Schmidt, N., & Witt, K. (2014). Konzept der hypodopaminergen und hyperdopaminergen Verhaltensstörungen bei Parkinson-Patienten. Aktuelle Neurologie. https://doi.org/10.1055/s-0034-1370239
447. Schneider, G. (2020). Diagnostik von psychischen Faktoren bei chronischem Pruritus. Der Hautarzt. https://doi.org/10.1007/s00105-020-04596-1
448. Schuckit, M. A. (1996). Alcohol, Anxiety, and Depressive Disorders.. PubMed.
449. Schulman, E. A. (2011). Abuse and Maltreatment: Their Effect on Headache. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2011.02020.x
450. Schutte, M., Mathias, B., & Hopf, G. (1988). [Adverse effects of antihistaminics].. PubMed.
451. Scotton, W. J., Hill, L. J., Williams, A., & Barnes, N. M. (2019). Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions. International Journal of Tryptophan Research. https://doi.org/10.1177/1178646919873925
452. Seiner, S., Baldessarini, R. J., Camprodon, J. A., Dougherty, D. D., Givon, L., DeVido, J., & Alpert, J. E. (2021). Psychopharmacology and Neurotherapeutics. Cambridge University Press eBooks. https://doi.org/10.1017/9780511846403.015
453. Sekhon, S., Patel, J., & Sapra, A. (2019). Late Onset Depression. StatPearls.
454. Sengupta, R., Roy, S., & Bhattacharya, M. (2019). STUDY OF GENE-ENVIRONMENT CAUSES OF MAJOR DEPRESSIVE DISORDER TO STATISTICALLY DEFINE THE MOST COMMON CAUSE BEHIND IT.. International Journal of Advanced Research. https://doi.org/10.21474/ijar01/8804
455. Shams, J., Rahmani, B., Asefi, F., & Daneshfar, S. (2010). CATATONIA DEVELOPMENT IN A SCHIZOAFFECTIVE PATIENT FOLLOWING ELECTROCONVULSIVE THERAPY: CASE REPORT.
456. Sharma, A. K., Rani, E., Waheed, A., & Rajput, S. K. (2015). Pharmacoresistant Epilepsy: A Current Update on Non-Conventional Pharmacological and Non-Pharmacological Interventions. Journal of Epilepsy Research. https://doi.org/10.14581/jer.15001
457. Sharpe, M. (2010). Chronic fatigue syndrome (postviral fatigue syndrome, neurasthenia, and myalgic encephalomyelitis). Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.260504
458. Sher, L. (2015). Parental alienation: the impact on men’s mental health. International Journal of Adolescent Medicine and Health. https://doi.org/10.1515/ijamh-2015-0083
459. Shields, L. B. E., Rolf, C. M., & Hunsaker, J. C. (2015). Sudden Death Due To Acute Cocaine Toxicity—Excited Delirium in a Body Packer. Journal of Forensic Sciences. https://doi.org/10.1111/1556-4029.12860
460. Shimamura, M., Nishizawa, K., & Yamashita, A. (1996). Effects of Kamikihi-to on ovariectomy-induced changes in behavior and circulation in rats.. Folia Pharmacologica Japonica. https://doi.org/10.1254/fpj.108.65
461. Shinohara, M., & Yamada, M. (2016). [Drug-induced Cognitive Impairment].. PubMed. https://doi.org/10.11477/mf.1416200415
462. Shirata, T., Yano, S., Noto, K., Kanno, M., & Suzuki, A. (2023). Jitteriness/anxiety syndrome caused by coadministration of celecoxib, a selective <scp>COX</scp>‐2 inhibitor, with escitalopram and trazodone in a patient with depression and spondylolisthesis. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.12325
463. Shou-zh, W. (2008). Drug Psychosis by Antipsychotic Drugs:Report of 40 Cases. Zhongguo quanke yixue.
464. Shprecher, D., & Mehta, L. (2010). The syndrome of delayed post-hypoxic  leukoencephalopathy.. PubMed.
465. Silver, R. M., & Airoldi, J. (2016). 27. Inherited thrombophilia. CRC Press eBooks. https://doi.org/10.1201/9781315200910-28
466. Simbolon, N. Y., Sitorus, T. R., Meliala, T. L., & Waruwu, P. (2020). TINJAUAN KRIMINOLOGI TERHADAP ANAK YANG MELAKUKAN TINDAK PIDANA PENYALAHGUNAAN NARKOTIKA. JURNAL ILMIAH SIMANTEK.
467. Simeon, D., & Abugel, J. (2006). Diagnosing Depersonalization Disorder. https://doi.org/10.1093/oso/9780195170221.003.0005
468. Singh, R. K., Chauhan, V. S., Panda, S. P., Prakash, J., & Chatterjee, K. (2023). Preeclamptic psychosis. Industrial Psychiatry Journal. https://doi.org/10.4103/ipj.ipj_246_23
469. Singh, S. (2015). Mental health in infancy. International Journal of Clinical & Medical Imaging. https://doi.org/10.4172/2376-0249.1000393
470. Skosnik, P. D., Sewell, R. A., García‐Sosa, I., Ranganathan, M., & D’Souza, D. C. (2010). Efeitos comportamentais, cognitivos e psicofisiológicos dos canabinoides: relevância para a psicose e a esquizofrenia. Brazilian Journal of Psychiatry. https://doi.org/10.1590/s1516-44462010000500005
471. Smith, B. D., Gupta, U., & Gupta, B. S. (2006). Arousal and Caffeine: Physiological, Behavioral, and Pathological Effects. CRC Press eBooks. https://doi.org/10.1201/9781420006568-1
472. Smith, P. J., & Blumenthal, J. A. (2015). Exercise and Physical Activity in the Prevention and Treatment of Depression. Routledge eBooks. https://doi.org/10.4324/9780203132678.ch8
473. Smitherman, T. A., Black, A. K., & Pellegrino, A. B. W. (2017). Migraine: Psychiatric Comorbidities. https://doi.org/10.2310/pm.6823
474. Sneep, A., Tjokrodipo, L., & Michielsen, P. (2021). A case of incubus phenomenon. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.2162
475. Snyder, S. H. (2019). CNS Stimulants And Hallucinogens. CRC Press eBooks. https://doi.org/10.1201/9780429260629-8
476. Soares, E. B., Pires, J. B., Menezes, M. D. A., Santana, S. K. S. D., & Fraga, J. (2010). Fonoaudiologia X ronco/apneia do sono. Revista CEFAC. https://doi.org/10.1590/s1516-18462010000200019
477. Solimini, R., Rotolo, M. C., Pichini, S., & Pacifici, R. (2017). Neurological Disorders in Medical Use of Cannabis: An Update. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/1871527316666170413105421
478. Sommer, I. E., & Arango, C. (2017). Moving interventions from after to before diagnosis. World Psychiatry. https://doi.org/10.1002/wps.20454
479. Song, S. Y., Pei, Y., Tippett, S. R., Lamichhane, D., Zallek, C. M., & Hsiao‐Wecksler, E. T. (2018). Validation of a Wearable Position, Velocity, and Resistance Meter for Assessing Spasticity and Rigidity. 2017 Design of Medical Devices Conference. https://doi.org/10.1115/dmd2018-6906
480. Sorayah, S. (2018). Uji Validitas Konstruk Beck Depression Inventory-II (BDI-II). DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.15408/jp3i.v4i1.9259
481. Spiegel, E. P., & Vanderploeg, R. D. (2010). Postconcussion Syndrome. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0696
482. Steefan, J. M., Siddesha, G., & Naveen, A. (2023). Adverse Effects of Antipsychotic Drugs - A Review. International Journal of Research and Review. https://doi.org/10.52403/ijrr.20230916
483. Stone, J., Carson, A., & Sharpe, M. (2005). Functional symptoms in neurology: management. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2004.061663
484. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
485. Stäubli, M. (1993). [Panic attacks].. PubMed.
486. Summerton, N. (2004). Evidence in practice — number 4: Restless legs. British Journal of General Practice.
487. Sung, H. C., & Chang, A. B. (2010). The effectiveness of preferred or familiar music listening on behavioural and psychological symptoms of institutionalised older adults with dementia: a systematic review. JBI Library of Systematic Reviews. https://doi.org/10.11124/jbisrir-2010-726
488. Sung, H. C., & Chang, A. B. (2010). The effectiveness of preferred or familiar music listening on behavioural and psychological symptoms of institutionalised older adults with dementia: a systematic review. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/01938924-201008341-00020
489. Swatko, T., Blicharz, M., Czubala, M., Bartosik-Zielińska, D., Blicharz, A., & Bartosik, M. (2023). Effects of creatine supplementation on brain in the healthy population. Journal of Education Health and Sport. https://doi.org/10.12775/jehs.2023.13.04.017
490. Sweet, G., Kim, S., Martin, S. A., Washington, N. B., & Brahm, N. C. (2017). Psychiatric symptoms and synthetic cannabinoid use: Information for clinicians. Mental Health Clinician. https://doi.org/10.9740/mhc.2017.07.156
491. Szyguła‐Jurkiewicz, B., Szymik, M., Mrozowska, B., Schmidt, B., & Michalak, A. (2011). Psychologiczne uwarunkowania i konsekwencje ostrego zawału serca. Leki psychotropowe u chorych po ostrym zawale serca. Choroby Serca i Naczyń.
492. Tacn, A. (2012). PTSD in the Context of Malignant Disease. InTech eBooks. https://doi.org/10.5772/27424
493. TAKANASHI, M. (2010). パーキンソン病の非運動症状. Juntendō Igaku/Juntendo igaku. https://doi.org/10.14789/pjmj.56.444
494. Tanaka, M., Tajima, S., Mizuno, K., Ishii, A., Konishi, Y., Miike, T., & Watanabe, Y. (2015). Frontier studies on fatigue, autonomic nerve dysfunction, and sleep-rhythm disorder. The Journal of Physiological Sciences. https://doi.org/10.1007/s12576-015-0399-y
495. Tatsuzawa, Y., Ono, Y., Takahashi, T., Yoshino, A., & Nomura, S. (2011). Case of isolated adrenocorticotropic hormone deficiency mimicking major depressive disorder. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.2011.02207.x
496. Thakur, A., Choudhary, D., Kumar, B., & Chaudhary, A. (2021). A Review on Post-traumatic Stress Disorder (PTSD): Symptoms, Therapies and Recent Case Studies. Current Molecular Pharmacology. https://doi.org/10.2174/1874467214666210525160944
497. Thompson, A., & Weber, A. (2021). Alcohol and Drug Withdrawal Syndromes and Their Clinical Management. DeckerMed Family Medicine. https://doi.org/10.2310/fm.13043
498. Thompson, A., & Weber, A. (2021). Alcohol and Drug Withdrawal Syndromes and Their Clinical Management. https://doi.org/10.2310/cannabis.13043
499. Thompson, A., & Weber, A. (2021). Alcohol and Drug Withdrawal Syndromes and Their Clinical Management. https://doi.org/10.2310/psych.13043
500. Thomsen, T., & Miyasaki, J. M. (2012). Psychogenic Movement Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-120-2_7
501. Tickner, N., Apps, J., Keady, S., & Sutcliffe, A. (2012). An overview of drug therapies used in the treatment of dystonia and spasticity in children. Archives of Disease in Childhood Education & Practice. https://doi.org/10.1136/archdischild-2011-301170
502. Timour, Q., Frassati, D., Descotes, J., Chevalier, P., Christé, G., & Chahine, M. (2012). Sudden Death of Cardiac Origin and Psychotropic Drugs. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2012.00076
503. Tito, E., Knapp, B., Bucca, A., & Espiridion, E. D. (2019). A Case Report of Schizoaffective Disorder with Pseudoseizures in a 42-year-old Male. Cureus. https://doi.org/10.7759/cureus.4835
504. Todd, O., & Teale, E. (2016). Delirium: a guide for the general physician. Clinical Medicine. https://doi.org/10.7861/clinmedicine.16-6-s98
505. Tong, G., Groom, K. N., Ward, L., & Naeem, M. Y. (2021). “This Is Not the Original Timeline”: A Case Report of an Extended Dissociative Episode in a Healthy Young Male Accompanied with Severe Decline in Mental State. Case Reports in Psychiatry. https://doi.org/10.1155/2021/6619579
506. Torpy, J. M. (2010). Delirium. JAMA. https://doi.org/10.1001/jama.304.7.814
507. Torre, R. D. L., Farré, M., Roset, P. N., Pizarro, N., Abanades, S., Segura, M., Segura, J., & Camı́, J. (2004). Human Pharmacology of MDMA. Therapeutic Drug Monitoring. https://doi.org/10.1097/00007691-200404000-00009
508. Touze, M.-D., Potel, G., & Baron, D. (1993). [Acute ethyl alcohol intoxication].. PubMed.
509. Toy, E. C., & Klamen, D. L. (2006). Case Files Psychiatry.
510. Tsai, S. (2019). Aged garlic extract supplement helps relieve acute stress. Journal of the Chinese Medical Association. https://doi.org/10.1097/jcma.0000000000000142
511. Tsatsakis, A., Docea, A. O., Călina, D., Tsarouhas, K., Zamfira, L.-M., Mitruț, R., Sharifi‐Rad, J., Kovatsi, L., Siokas, V., Dardiotis, E., Drakoulis, N., Lazopoulos, G., Tsitsimpikou, C., Mitsias, P., & Neagu, M. (2019). A Mechanistic and Pathophysiological Approach for Stroke Associated with Drugs of Abuse. Journal of Clinical Medicine. https://doi.org/10.3390/jcm8091295
512. Udangiu, L. N., Roventa, C. E., & Teodorescu, D. (2010). Clinical and Therapeutic Management of Acute Stress Disorder. Management in Health. https://doi.org/10.5233/mih.2010.0013
513. Uddin, M. S., Sufian, M. A., Kabir, M. T., Hossain, M. F., Nasrullah, M., Islam, I., Mamun, A. A., Islam, M. T., & Khanum, S. (2017). Amphetamines: Potent Recreational Drug of Abuse. Journal of Addiction Research & Therapy. https://doi.org/10.4172/2155-6105.1000330
514. Ullah, M. (2023). DIAGNOSIS OF FIBROMYALGIA IN HEALTH PRACTICE. Northwest journal of medical sciences.. https://doi.org/10.69723/njms.02.04.0370
515. Umut, G., Küçükparlak, İ., Özgen, G., & Türkcan, A. (2011). Esrar Kullanımı Sırasında Başlayan ve N, N- Dimetiltriptamin (Dmt) Kullanımı ile Psikotik Özellikler Eklenen Duygudurum Bozukluğu: Bir Olgu Sunumu / A Mood Disorder Episode with an Onset Under Chronic Cannabis Consumption, and Accompanied With Psychotic Features Immediately After N,N-Dimethyltryptamine (Dmt) Use: A Case Report. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. https://doi.org/10.5350/dajpn2011240312
516. Valente, S. M. (2015). Evaluating and Managing Insomnia: Non-pharmacological Treatments. Journal of Sleep Disorders & Therapy. https://doi.org/10.4172/2167-0277.1000189
517. Vandewalle, W., Boon, E., & Sienaert, P. (2015). [Movement disorders due to modern antidepressants and mood stabilizers].. PubMed.
518. Varshney, A., Kumar, S., Gupta, V. P., Mateen, R., & Azmi, S. A. (2022). Intravenous Ketamine-induced Affective Switch in a Patient of Major Depressive Disorder with Suicidal Ideation: A Case Report. Indian Journal of Behavioural Sciences. https://doi.org/10.55229/ijbs.v25i2.14
519. Varı̀, M. R., Pichini, S., Giorgetti, R., & Busardò, F. P. (2018). New psychoactive substances—Synthetic stimulants. Wiley Interdisciplinary Reviews Forensic Science. https://doi.org/10.1002/wfs2.1197
520. Vasconcelos, L. P. B., Gandini, J., Teixeira, A., & Manto, M. (2022). Movement Disorders Associated With Stimulants and Other Drugs of Abuse. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197574317.003.0009
521. Velasco-Rey, M. C., Sánchez-Muñoz, M., Lopez, M., Trujillo-Borrego, A., & Sánchez-Bonome, L. (2012). Psychotic depression induced by Obstructive Sleep Apnoea Syndrome (OSAS): a case reported.. PubMed.
522. Venkataraman, R., Patodia, S., & Thiriveedhi, R. N. (2023). Thrombocytopenia in the Critically Ill: An Animal with Several Heads. Indian Journal of Critical Care Case Report. https://doi.org/10.5005/jp-journals-11006-0089
523. Verbraeken, R., & Luykx, J. J. (2018). Persistent catatonia following epileptic seizures: a case report and systematic literature search. BMC Psychiatry. https://doi.org/10.1186/s12888-018-1935-0
524. Verhoeff, M. C., Baat, C. D., Ahlberg, J., Manfredini, D., Winocur, E., Zweers, P. G., Rozema, F. R., Vissink, A., & Lobbezoo, F. (2020). Medications and addictive substances potentially inducing or attenuating sleep bruxism and/or awake bruxism. Journal of Oral Rehabilitation. https://doi.org/10.1111/joor.13061
525. Vezzosi, D., Bennet, A., Maïza, J.-C., Buffet, A., Grunenwald, S., Fauvel, J., Courbon, F., Otal, P., Carrère, N., & Caro, P. (2011). Diagnosis and Treatment of Insulinomas in the Adults. InTech eBooks. https://doi.org/10.5772/17452
526. Vicente, M. O., Gutiérrez, L. E. J. F., & Oves, M. I. R. (2011). ALCOHOLISMO CONSECUTIVO AL TRASTORNO DE PÁNICO. DOAJ (DOAJ: Directory of Open Access Journals).
527. Vilke, G. M., & Ly, B. T. (2022). Clinical Syndromes and Emergency Room Physician and Management Issues. CRC Press eBooks. https://doi.org/10.4324/9781315155159-1
528. Vlaminck, J., Vliet, I. M. V., & Zitman, F. (2005). [Withdrawal symptoms of antidepressants].. PubMed.
529. Volder, I. D. (2006). Periodic limb movement disorder and restless legs syndrome. Breathe. https://doi.org/10.1183/18106838.0203.250
530. Vuppalapati, C., Kedari, S., Ilapakurti, A., Kedari, S., & Shankar, J. (2019). Emotional Health: A Data Driven Approach to Understand our Emotions and Improve our Health. https://doi.org/10.1109/cse/euc.2019.00071
531. Wahyuningsih, S., Nurun, N., Ainul, A., Rendra, R., & Dwiki, D. (2020). Relaksasi Nafas Dalam Terhadap Tingkat Kecemasan Pada Lansia Yang Menderita Hipertensi Di RT 03 RW 09 Kelurahan Slipi Palmerah Jakarta Barat. JURNAL KREATIVITAS PENGABDIAN KEPADA MASYARAKAT (PKM). https://doi.org/10.33024/jkpm.v3i2.3194
532. Walker, A. E. (2023). Custody and Restraint Deaths. CRC Press eBooks. https://doi.org/10.1201/9781003138754-30
533. Waller, D. G., Renwick, A., & Hillier, K. (2010). Medical Pharmacology and Therapeutics.
534. Walterscheid, B., Eshak, N., & Nugent, K. (2021). Altered mental status in a patient with psychiatric history: Medication noncompliance or medical etiology?. Journal of Investigative Medicine.
535. Walther, M., & Woods, D. W. (2010). Trichotillomania. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy1011
536. Wand, G. S. (2008). The influence of stress on the transition from drug use to addiction.. PubMed.
537. Ware, W. A., Bonagura, J. D., & Scansen, B. A. (2021). Exercise Intolerance. CRC Press eBooks. https://doi.org/10.1201/9780429186639-9
538. WATKINS, P. C. (1997). Treatment of Symptomatic Mitral Valve Prolapse Syndrome and Dysautonomia. Cardiology in Review. https://doi.org/10.1097/00045415-199707000-00011
539. Weintraub, D. (2009). Dopamine and impulse control disorders in Parkinson's disease. Annals of Neurology. https://doi.org/10.1002/ana.21454
540. Werf, C. V. D., Langen, I. M. V., & Wilde, A. A. (2010). Sudden Death in the Young. Circulation Arrhythmia and Electrophysiology. https://doi.org/10.1161/circep.109.877142
541. Wiebe, D. J., Comstock, R. D., & Nance, M. L. (2011). Concussion research: a public health priority. Injury Prevention. https://doi.org/10.1136/ip.2010.031211
542. Wiglusz, M. S., Cubała, W. J., Nowak, P. M., Jakuszkowiak‐Wojten, K., Landowski, J., & Krysta, K. (2013). Sibutramine-associated psychotic symptoms and zolpidem-induced complex behaviours: implications for patient safety.. PubMed.
543. Wijdicks, E. F. M. (2025). “Blacked Out and Slumped Down”. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197544976.003.0007
544. Williams, R. H., & Erickson, T. B. (2000). Evaluating Hallucinogenic or Psychedelic Drug Intoxication in an Emergency Setting. Laboratory Medicine. https://doi.org/10.1309/v3j8-3kw2-bpt1-fu15
545. Williams, R. H., Erickson, T. B., & Broussard, L. A. (2000). Evaluating Sympathomimetic Intoxication in an Emergency Setting. Laboratory Medicine. https://doi.org/10.1309/wvx1-6fpv-e2lc-b6yg
546. Wilson, B. (1991). The Effect of Drugs on Male Sexual Function and Fertility. The Nurse Practitioner. https://doi.org/10.1097/00006205-199109000-00009
547. Wilson, K. C., & Saukkonen, J. (2004). Acute Respiratory Failure from Abused Substances. Journal of Intensive Care Medicine. https://doi.org/10.1177/0885066604263918
548. Winger, G., Woods, J. H., & Hofmann, F. G. (2004). Central Nervous System Stimulants: Cocaine, Amphetamines, Related Drugs, and Caffeine. https://doi.org/10.1093/oso/9780195172782.003.0008
549. Wissow, L. S. (2021). Anxiety and Trauma-Related Distress. Pediatric Care Online. https://doi.org/10.1542/aap.ppcqr.396464
550. Wolkowitz, O. M., Burke, H., Epel, E. S., & Reus, V. I. (2009). Glucocorticoids. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2009.04980.x
551. Wood, S., Sage, J. R., Shuman, T., & Anagnostaras, S. (2013). Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation. Pharmacological Reviews. https://doi.org/10.1124/pr.112.007054
552. Wyatt, J. P., Illingworth, R. N., Graham, C. A., Hogg, K., Clancy, M., & Robertson, C. E. (2012). Environmental emergencies. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199589562.003.0006
553. Yates, S. J., Ahuja, N., Gartside, S. E., & McAllister‐Williams, R. H. (2011). Serotonin syndrome following introduction of venlafaxine following withdrawal of phenelzine: implications for drug washout periods. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125311413497
554. Yennurajalingam, S., & Bruera, É. (2015). Fatigue and asthenia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199656097.003.0081
555. Yoshimura, S., & Imai, K. (1990). PATHOLOGICAL STUDY ON NEUROTOXICITY OF DRUGS. Journal of Toxicologic Pathology. https://doi.org/10.1293/tox.3.65
556. Youssef, P. E., Mack, K. J., & Flemming, K. D. (2015). Classification and Approach to Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190244927.003.0024
557. Yui, K., Kajii, Y., & Nishikawa, T. (2006). Neurobiological and Molecular Bases of Methamphetamine-Induced Behavioral Sensitization and Spontaneous Recurrence of Methamphetamine Psychosis, and its Implication in Schizophrenia. Current Psychiatry Reviews. https://doi.org/10.2174/157340006778018111
558. Zagnoni, P., & Albano, C. (2002). Psychostimulants and Epilepsy. Epilepsia. https://doi.org/10.1046/j.1528-1157.2002.043s2028.x
559. Zanini, R. S., Almeida, G. M. F. D., Helegda, L. C., & Fernandes, K. C. (2014). DEMENCIA DE WERNICKE KORSAKOFF, USO E ABUSO DE SUBSTANCIAS: REPERCUSSÕES NEUROPSICOLÓGICAS E PSICOMOTORAS.. Fiep Bulletin - online.
560. Zawilska, J. B., & Tomaszewska, A. (2019). Psychoactive substances used to increase sexual activity: chemsex. Farmacja Polska. https://doi.org/10.32383/farmpol/116296
561. Zouari, R., Nabli, F., Mohamed, D. B., Saeid, M. Z., & Sassi, S. B. (2023). Toxic encephalopathy after an overdose of cocaine : a case serie. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.1403
562. Šostar, Z., Vodanović, M., Breitenfeld, D., Breitenfeld, T., Buljan, D., & Granić, R. (2009). Composers - Substance Abusers. Alcoholism and psychiatry research Journal on psychiatric research and addictions.
563. Оstroumova, Т. М., & Tolmacheva, V. A. (2022). Drug-induced tremor. Neurology neuropsychiatry Psychosomatics. https://doi.org/10.14412/2074-2711-2022-2-4-10
564. Оstroumova, Т. М., Kulikova, M., & De, V. (2022). Drug-induced hypertension. Medical alphabet. https://doi.org/10.33667/2078-5631-2022-3-8-13